<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Aging Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Aging Dis</journal-id>
<journal-title-group>
<journal-title>Aging and Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">2152-5250</issn>
<publisher>
<publisher-name>JKL International LLC</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29896440</article-id>
<article-id pub-id-type="pmc">5988607</article-id>
<article-id pub-id-type="publisher-id">ad-9-3-537</article-id>
<article-id pub-id-type="doi">10.14336/AD.2017.0702</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mammalian Sterile20-like Kinases: Signalings and Roles in Central Nervous System</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Chen</surname>
<given-names>Sheng</given-names>
</name>
<xref ref-type="aff" rid="aff1-ad-9-3-537">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn1-ad-9-3-537">
<sup>#</sup>
</xref>
<xref ref-type="corresp" rid="cor1-ad-9-3-537">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Fang</surname>
<given-names>Yuanjian</given-names>
</name>
<xref ref-type="aff" rid="aff1-ad-9-3-537">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn1-ad-9-3-537">
<sup>#</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Shenbin</given-names>
</name>
<xref ref-type="aff" rid="aff1-ad-9-3-537">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reis</surname>
<given-names>Cesar</given-names>
</name>
<xref ref-type="aff" rid="aff2-ad-9-3-537">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3-ad-9-3-537">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jianmin</given-names>
</name>
<xref ref-type="aff" rid="aff1-ad-9-3-537">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4-ad-9-3-537">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="cor1-ad-9-3-537">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1-ad-9-3-537">
<addr-line><sup>1</sup>Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.</addr-line></aff>
<aff id="aff2-ad-9-3-537">
<addr-line><sup>2</sup>Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, California, USA.</addr-line></aff>
<aff id="aff3-ad-9-3-537">
<addr-line><sup>3</sup>Brain Research Institute, Zhejiang University, Hangzhou, Zhejiang, China.</addr-line></aff>
<aff id="aff4-ad-9-3-537">
<addr-line><sup>4</sup>Collaborative Innovation Center for Brain Science, Zhejiang University, Hangzhou, Zhejiang, China.</addr-line></aff>
<author-notes>
<corresp id="cor1-ad-9-3-537"><label>*</label>Correspondence should be addressed to: Drs. Sheng Chen, and Jianmin Zhang, The Second Affiliated Hospital, School of Medicine, Zhejiang University, China Email: <email>saintchan@zju.edu.cn</email> and <email>zjm135@vip.sina.com.</email></corresp>
<fn id="fn1-ad-9-3-537">
<label>#</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>3</issue>
<fpage>537</fpage>
<lpage>552</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="rev-request">
<day>16</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>7</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: Â© 2018 Chen et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<abstract>
<p>Mammalian Sterile20-like (MST) kinases are located upstream in the mitogen-activated protein kinase pathway, and play an important role in cell proliferation, differentiation, renewal, polarization and migration. Generally, five MST kinases exist in mammalian signal transduction pathways, including MST1, MST2, MST3, MST4 and YSK1. The central nervous system (CNS) is a sophisticated entity that takes charge of information reception, integration and response. Recently, accumulating evidence proposes that MST kinases are critical in the development of disease in different systems involving the CNS. In this review, we summarized the signal transduction pathways and interacting proteins of MST kinases. The potential biological function of each MST kinase and the commonly reported MST-related diseases in the neural system are also reviewed. Further investigation of MST kinases and their interaction with CNS diseases would provide the medical community with new therapeutic targets for human diseases.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Mammalian Sterile20-like kinases</kwd>
<kwd>central nervous system disorders</kwd>
<kwd>mitogen-activated protein kinase</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Mitogen-activated protein kinases (MAPKs) signal cascades are highly conserved across eukaryotes and have a pivotal role in meditating cell proliferation, cell differentiation, stress-related response and cell death [<xref ref-type="bibr" rid="b1-ad-9-3-537">1</xref>]. These cascades consist of three-tiered kinases (MAPKs, MAPK kinases and MAPK kinase kinases), which transduce developmental and environmental stimuli signals to the target proteins [<xref ref-type="bibr" rid="b2-ad-9-3-537">2</xref>]. Sterile 20 (STE20) kinases are located upstream in the MAPK pathway in budding yeast, subsequently invoking the MAPK kinases to initiate the MAPKs [<xref ref-type="bibr" rid="b3-ad-9-3-537">3</xref>, <xref ref-type="bibr" rid="b4-ad-9-3-537">4</xref>]. According to their distinct structures and functions, STE20 kinases can be broadly divided into two subfamilies, p21Rac/Cdc42-activated kinases (PAKs) [<xref ref-type="bibr" rid="b5-ad-9-3-537">5</xref>] and germinal center kinases (GCKs) [<xref ref-type="bibr" rid="b6-ad-9-3-537">6</xref>]. As the mammalian homologues of STE20, Mammalian Sterile20-like (MST) kinases considered as a part of the GCK subfamily [<xref ref-type="bibr" rid="b7-ad-9-3-537">7</xref>]. Research demonstrated that MST kinases play an essential role in responding to control of organogenesis, organ size, and immune formation by regulating cell proliferation, differentiation, renewal, polarization, and migration [<xref ref-type="bibr" rid="b8-ad-9-3-537">8</xref>-<xref ref-type="bibr" rid="b11-ad-9-3-537">11</xref>].</p>
<p>The central nervous system (CNS) is a sophisticated entity, with two parts including brain and spinal cord. CNS takes charge of information reception, integration, and responses derived from messages provided by the many organ systems of the body. Several pathophysiological mechanisms participate in development of CNS diseases and injuries, such as neural apoptotic and necrosis, oxidative damage, inflammation, ischemia, demyelination, excitotoxicity and injuries of astrocytes, oligodendrocytes, and axonal and genetic disorders [<xref ref-type="bibr" rid="b12-ad-9-3-537">12</xref>-<xref ref-type="bibr" rid="b14-ad-9-3-537">14</xref>]. These alterations in CNS would normally result in sensory, motor and cognitive dysfunction or even death. Spontaneous regeneration of neurons is not possible, leaving few treatment options for patients with CNS injuries or diseases [<xref ref-type="bibr" rid="b15-ad-9-3-537">15</xref>, <xref ref-type="bibr" rid="b16-ad-9-3-537">16</xref>].</p>
<p>
<fig id="F1-ad-9-3-537" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Signaling network of MST1 and MST2 kinase. The signaling pathways of MST1/2 mainly include MST1/2-YAP/TAZ signaling pathway and MST1/2-FOXO signaling pathway. MST1/2 phosphorylates the downstream Lats1/2 and subsequently inhibits the transcriptional function of intranuclear YAP/TAZ, avoiding the excessive cell proliferation and organ overgrowth. The MST1/2 can also mediate this signaling pathway by suppressing GABA function. The MST1/2-FOXO signaling pathway mainly regulates the apoptosis process. MST1/2 phosphorylates AKT and subsequently disrupts its function of interaction between FOXO3 with 14-3-3 proteins. This indirectly promotes apoptosis process. In addition, Mst1 promotes the proapoptotic mediator NOXA transcription via the assistance of FOXO1. The MST1-induced JNK activation can also promote apoptosis. Several interacting partners such as RASSF members, DAP4, acinus and Raf-1 also combine with the MST1/2 and perform different biological functions.</p></caption><graphic xlink:href="ad-9-3-537-g1"></graphic></fig></p>
<p>Given the potent effects of MST signaling networks on different biological functions, MSTs are evolving in the development of several diseases including cancer[<xref ref-type="bibr" rid="b17-ad-9-3-537">17</xref>], endothelial pathologies[<xref ref-type="bibr" rid="b18-ad-9-3-537">18</xref>], autoimmunity[<xref ref-type="bibr" rid="b19-ad-9-3-537">19</xref>] and organ dysplasia[<xref ref-type="bibr" rid="b20-ad-9-3-537">20</xref>, <xref ref-type="bibr" rid="b21-ad-9-3-537">21</xref>]. Recently, accumulating evidences have demonstrated how MST kinases play important roles in neuronal signal pathway and development of CNS diseases[<xref ref-type="bibr" rid="b22-ad-9-3-537">22</xref>-<xref ref-type="bibr" rid="b25-ad-9-3-537">25</xref>]. Therefore, a circumstantial recognition of the roles MST kinases play in the CNS would significantly broaden the horizon on potential targets for therapy to treat neuronal diseases. This review focuses on the biological function and underlying mechanism of MST kinases in the pathogenesis of diseases in CNS.</p>
<sec>
<title>Signaling Network and Biological Functions of MST Kinases</title>
<p>In general, there are five MST kinases including MST1 or serine/threonine-protein kinase 4 (STK4), MST2 (STK3), MST3 (STK24), MST4 (STK26), and YSK1 (STK25) that exist in mammalian signal transduction pathways [<xref ref-type="bibr" rid="b26-ad-9-3-537">26</xref>]. MST1 and MST2 (Hippo pathway in Drosophila) are considered as the members of germinal center kinase (GCK) II subfamily. The MST3, MST4, and YSK1 are divided into the GCKIII subfamily [<xref ref-type="bibr" rid="b7-ad-9-3-537">7</xref>, <xref ref-type="bibr" rid="b27-ad-9-3-537">27</xref>]. With assistance from the sequence analysis and function data, it was accepted that the yeast kinases Cdc15 and Sid1 are most matched to MST1 and MST2, while Kic1 and Nak1 in yeast are most matched to the MST3, MST4, and YSK1 [<xref ref-type="bibr" rid="b26-ad-9-3-537">26</xref>]. The biological functions of these kinases include their roles in signal transduction pathways which help maintain cell homeostasis. Here we introduced these kinases in two parts: MST1 and MST2 (<xref ref-type="fig" rid="F1-ad-9-3-537">Fig. 1</xref>); MST3, MST4 and YSK1 (<xref ref-type="fig" rid="F2-ad-9-3-537">Fig. 2</xref>).</p>
<p>
<fig id="F2-ad-9-3-537" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Signaling network of MST3, MST4 and YSK1 kinase. MST3, MST4 and YSK1 located on the Golgi apparatus with the assistance of GM130 and Striatin proteins. Unlike MST3 and MST4, YSK1 acts a positive role when localized to the Golgi via interaction with 14-3-3. This link potentially mediates the protein transport, cell polarity and cell adhesion. CCM3 or Mo25 induces the movement of MST3 and MST4 from the Golgi apparatus to the plasma membrane. Activated MST3/4 can promote co-localization of the actomyosin with help of Ezrin. Besides, MST3 inhibit PTP-PEST and prevent PTP-PEST dependent paxillin phosphorylation which consequently attenuates the cell migration. MST3 also can activate the NDR protein kinases to regulate the apoptosis process.</p></caption><graphic xlink:href="ad-9-3-537-g2"></graphic></fig></p>
</sec>
<sec>
<title>MST1 and MST2</title>
<p>With the assistance of cofactor WW-domain scaffolding protein WW45 (Sav in Drosophila), MST1/2 binds and phosphorylates the downstream Nuclear Dbf2-related (NDR) family kinases and Large tumor suppressor (Lats1/2, as Warts in Drosophila), through interaction with SARAH domains [<xref ref-type="bibr" rid="b28-ad-9-3-537">28</xref>]. Meanwhile, phosphorylation of Mps one binder kinase activator-like 1 (Mob1, Mats in Drosophila) a/b by MST1/2 promotes the integration between Mob1a/b and Lats1/2 and actives the Lats1/2 [<xref ref-type="bibr" rid="b29-ad-9-3-537">29</xref>]. With the induction of Lats1/2, two intranuclear transcriptional regulators, Yes-associated protein (YAP) and Transcriptional coactivator with PDZ-binding motif (TAZ), which are similar as Yki in Drosophila, interact with 14-3-3 proteins and subsequently lose their function in cytoplasm [<xref ref-type="bibr" rid="b30-ad-9-3-537">30</xref>]. This mechanism negatively attenuates transcription activity from losing interaction between YAP/TAZ and their target genes. Intranuclear YAP interacts with the TEAD1-4 transcription factor to stimulate cell proliferation and against the cellular death [<xref ref-type="bibr" rid="b31-ad-9-3-537">31</xref>]. Thus, the mammalian Hippo pathway avoids excessive proliferation and organ overgrowth in stem cells [<xref ref-type="bibr" rid="b31-ad-9-3-537">31</xref>, <xref ref-type="bibr" rid="b32-ad-9-3-537">32</xref>]. A recent study found that MST1 and MST2 signal also inhibits YAP function by suppressing GA-binding protein (GABP) transcriptional activity [<xref ref-type="bibr" rid="b33-ad-9-3-537">33</xref>]. Additionally, the Hippo pathway can regulate polarization of the F-actin cytoskeleton in epithelial cells and migrating border cells [<xref ref-type="bibr" rid="b34-ad-9-3-537">34</xref>, <xref ref-type="bibr" rid="b35-ad-9-3-537">35</xref>]. This mechanism was demonstrated in the Drosophila through inhibiting the Ena/Capping protein system instead of Yki [<xref ref-type="bibr" rid="b34-ad-9-3-537">34</xref>, <xref ref-type="bibr" rid="b35-ad-9-3-537">35</xref>].</p>
<p>MST1 and MST2 kinase can also activating phosphorylation of the forkhead box proteins (FOXO) and subsequently promote the proapoptotic genes expression [<xref ref-type="bibr" rid="b7-ad-9-3-537">7</xref>, <xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>]. MST-FOXO pathway is mainly initiated under the circumstances of stress. It regulates cell death by means of phosphorylating FOXO1 at serine 212 or the FOXO3 at serine 207 in neurons [<xref ref-type="bibr" rid="b22-ad-9-3-537">22</xref>, <xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>]. Meanwhile, MST1 and MST2 can also phosphorylate the survival kinase AKT and inhibit its activation on FOXO3, indirectly disrupting its interaction with 14-3-3 proteins and promoting the apoptosis [<xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>, <xref ref-type="bibr" rid="b37-ad-9-3-537">37</xref>]. MST1 promotes the proapoptotic mediator NOXA transcription via the assistance of FOXO1. This signaling pathway mainly works in controlling apoptosis in cancer cells [<xref ref-type="bibr" rid="b37-ad-9-3-537">37</xref>]. Additionally, recent finding show how MST1/2 phosphorylates and stabilizes the transcription factor forkhead box A2 (FOXA2), which plays an essential role in the regulation of pneumocyte maturation and surfactant homeostasis [<xref ref-type="bibr" rid="b38-ad-9-3-537">38</xref>]. Lastly, the MST1-FOXO signaling pathway is beneficial for the immune system in maintaining naive T cell homeostasis [<xref ref-type="bibr" rid="b39-ad-9-3-537">39</xref>].</p>
<p>
<fig id="F3-ad-9-3-537" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Regulators of MST1 and MST2. Several regulators are involved in the MST1/2 signaling pathway. AMOT2 protein may potentially activate the Hippo-YAP pathway by sensing the mechanical alteration from the cell-cell junction. With the assistance GPCR, biological activation mediate Lats1/2 function in different circumstances. In addition, the SAV1/WW45 and RASSF can activate the MST1/2 through the interaction with SARAH domain. Caspase proteins from apoptotic processes can cleave the MST1/2 and promote human Hippo pathway. While PP2A, STRIPAK complex and TAO may own the potential effect on this pathway.</p></caption><graphic xlink:href="ad-9-3-537-g3"></graphic></fig></p>
<p>Another downstream protein of MST1, JNK, is activated under the induction of discharged or overexpressed MST1, which was shown to be important for chromatin condensation during apoptosis[<xref ref-type="bibr" rid="b40-ad-9-3-537">40</xref>]. A previous study proved the MST1 and MST2 can activate the JNK-SAPK pathway to induce cell cycle arrest, apoptosis, or cell survival in response to the actin cytoskeleton disruption [<xref ref-type="bibr" rid="b41-ad-9-3-537">41</xref>]. Some studies show that MST1 and MST2 have several interacting partners, including RASSF members, DAP4, acinus and Raf-1. They combine with the MST1 and MST2 and promote different biological functions in cellular signal pathway [<xref ref-type="bibr" rid="b7-ad-9-3-537">7</xref>].</p>
<p>
<fig id="F4-ad-9-3-537" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Regulators of MST3 and MST4 and YSK1. The biological function of MST3, MST4 and YSK1 kinases mainly depend on the interaction with GM130, Mo25 and CCM3 binding proteins. Caspase proteins from apoptosis, PP2A and STRIPAK complex also can regulate MST3 or MST4.</p></caption><graphic xlink:href="ad-9-3-537-g4"></graphic></fig></p>
</sec>
<sec>
<title>MST3, MST4 and YSK1</title>
<p>Compared to the MST1 and MST2 kinases, less is known about MST3, MST4, and YSK1 kinases. The MST3, MST4, and YSK1 kinases play essential roles in regulation of cell polarity, cell adhesion, and cell migration. Normally, with assistance of different Golgi matrix proteins, these three kinases are recruited to the Golgi apparatus [<xref ref-type="bibr" rid="b11-ad-9-3-537">11</xref>, <xref ref-type="bibr" rid="b42-ad-9-3-537">42</xref>, <xref ref-type="bibr" rid="b43-ad-9-3-537">43</xref>]. GM130 may be the common protein of MST4 and YSK1 that help target the Golgi apparatus. MST3 localize on the Golgi through interaction with Striatin proteins [<xref ref-type="bibr" rid="b11-ad-9-3-537">11</xref>, <xref ref-type="bibr" rid="b43-ad-9-3-537">43</xref>, <xref ref-type="bibr" rid="b44-ad-9-3-537">44</xref>], and this interactions inactives MST3 and MST4. In contrast, YSK1 binding the GM130 may play a positive role on Golgi apparatus. The biochemical screening identifies YSK1 as locating to the Golgi apparatus via a special substrate, 14-3-3 proteins. This link causes potential concern for protein transport, cell polarity, and cell adhesion[<xref ref-type="bibr" rid="b11-ad-9-3-537">11</xref>]. The adaptor proteins, cerebral cavernous malformation 3 (CCM3) protein or Mo25 can induce the movement of MST3 and MST4 from the Golgi apparatus to the plasma membrane. Active MST3 and MST4 promote the co-localization of the actomyosin with the help of Ezrin protein [<xref ref-type="bibr" rid="b26-ad-9-3-537">26</xref>, <xref ref-type="bibr" rid="b45-ad-9-3-537">45</xref>]. In addition, MST3 directly phosphorylates the downstream protein-tyrosine phosphatase (PTP)-PEST and inhibits the activity of tyrosine phosphatase activity on PTP-PEST. This reaction inhibits the PTP-PEST dependent paxillin phosphorylation and consequently attenuates cell migration [<xref ref-type="bibr" rid="b42-ad-9-3-537">42</xref>]. The PTP-PEST is involved in actin cytoskeleton regulation and actively contributes to the cellular apoptotic response [<xref ref-type="bibr" rid="b46-ad-9-3-537">46</xref>]. As in the pathway of MST1 and MST2 on Lats, MST3 can phosphorylate and activate the NDR protein kinases at the site of Thr442/Thr444. It also regulates cell cycle progression and morphology control [<xref ref-type="bibr" rid="b47-ad-9-3-537">47</xref>]. However, evidence of MST4 or YSK1 directly phosphorylating NDR protein kinases in mammalian systems remains unclear [<xref ref-type="bibr" rid="b48-ad-9-3-537">48</xref>].</p>
</sec>
<sec>
<title>Regulation of MST kinases</title>
<p>Regulation of MST kinases is complicated and the current studies on regulatory mechanisms are not well understood. Here we conclude with several potential regulator signals of MST kinases (<xref ref-type="fig" rid="F3-ad-9-3-537">Fig. 3</xref> and <xref ref-type="fig" rid="F4-ad-9-3-537">Fig. 4</xref>)</p>
<p>MST1 and MST2 kinase play important roles in cell proliferation and tissue size via the MST1/2-YAP/TAZ signal pathway. However, the upstream regulator of this pathway remains unclear. The angiomotin 2 (AMOT2) protein may be the potential activator of Hippo-YAP pathway by sensing the mechanical alteration from the cell-cell junction [<xref ref-type="bibr" rid="b49-ad-9-3-537">49</xref>, <xref ref-type="bibr" rid="b50-ad-9-3-537">50</xref>]. The G-protein-coupled receptor (GPCR) signaling modulates the Hippo-YAP pathway through controlling Lats1/2 activity. In abnormal conditions, serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) stimulate the G12/13-coupled receptors to inhibit the Lats1/2 function. In contrast, glucagon and epinephrine induce GPCR and activate the Lats1/2 function in the homeostatic condition [<xref ref-type="bibr" rid="b51-ad-9-3-537">51</xref>].</p>
<p>The MST1 and MST2 kinase can also be regulated through the SARAH domain, which promotes MST1 trans-autophosphorylation and the MST2 activation loop catalyzed within the homodimer [<xref ref-type="bibr" rid="b52-ad-9-3-537">52</xref>]. The SARAH domain is a specialized coiled coil domain near the C-terminal of MST1 and MST2, named from the three gene families, Salvador(SAV1)/WW45, RASSF and Hippo/Mst1/Mst2 [<xref ref-type="bibr" rid="b53-ad-9-3-537">53</xref>]. The SARAH domain binds to RASSF family proteins and SAV1,positively stimulating MST1/2 activity [<xref ref-type="bibr" rid="b54-ad-9-3-537">54</xref>, <xref ref-type="bibr" rid="b55-ad-9-3-537">55</xref>]. Previous studies showed cleavage sites of MST1/2 caspases located on the distal catalytic domain can be activated during apoptosis[<xref ref-type="bibr" rid="b56-ad-9-3-537">56</xref>-<xref ref-type="bibr" rid="b58-ad-9-3-537">58</xref>]. The caspase cleaved ~36kDa Mst1/2 polypeptides can also initiate nuclear access of human Hippo pathway, which is less impeded than the traditional pathway. However the exact mechanism is still unknown [<xref ref-type="bibr" rid="b52-ad-9-3-537">52</xref>].</p>
<p>Furthermore, Hippo activities can also be regulated by the protein phosphatase (PP) 2A, Striatin Interacting Phosphatase and Kinase (STRIPAK) complex and TAO kinases in the Drosophila studies [<xref ref-type="bibr" rid="b59-ad-9-3-537">59</xref>, <xref ref-type="bibr" rid="b60-ad-9-3-537">60</xref>]. Despite the known interactive effects of these regulators with the mammalian MST1 and MST2 details remain vague and requires more investigative studies.</p>
<p>The regulators of MST3, MST4, and YSK1kinases include GM130, Mo25 and CCM3 binding protein, and STRIPAK. As discussed above, the MST3, MST4, and YSK1 kinases play different roles in the cellular functions by combining different adaptor proteins (GM130, Mo25 and CCM3) and their locations. One study suggested that apoptotic regulatory protein caspase are able to mediate the proteolytic activation of MST3. With the assistance of this mechanism, nuclear translocation and apoptosis were induced [<xref ref-type="bibr" rid="b61-ad-9-3-537">61</xref>]. Suppression of PP2A activity or disruption of STRIPAK complex promotes the phosphorylation of the activation loop of MST3 and MST4 [<xref ref-type="bibr" rid="b45-ad-9-3-537">45</xref>].</p>
<table-wrap id="T1-ad-9-3-537" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Main findings of MST kinases in CNS biological function.</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="background-color:#5F9BBC" valign="top">Author/Year</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#5F9BBC" valign="top">MST kinase</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#5F9BBC" valign="top">Signaling pathway</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#5F9BBC" valign="top">Main function</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Lehtinenet al.[<xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>]/2006</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1-FOXO3</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates oxidative-stress-induced cell death</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Yuan et al.[<xref ref-type="bibr" rid="b22-ad-9-3-537">22</xref>]/2009</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1-FOXO1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Mediates survival factor deprivation-induced cell death</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Xiao et al.[<xref ref-type="bibr" rid="b67-ad-9-3-537">67</xref>]/2011</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">c-Abl-MST1-FOXO3</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates oxidative-stress-induced cell death</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Yun et al.[<xref ref-type="bibr" rid="b70-ad-9-3-537">70</xref>]/2011</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">IFN-Î³-Daxx-MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Mediates proinflammatory-cytokine-induced cell death</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Lee et al.[<xref ref-type="bibr" rid="b68-ad-9-3-537">68</xref>]/2014</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">MT3-zin-c-Abl-MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates oxidative-stress-induced cell death</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Liu et al.[<xref ref-type="bibr" rid="b25-ad-9-3-537">25</xref>]/2012</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST2</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">c-Abl-MST2</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Mediates oxidative-stress-induced cell death</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Tang et al.[<xref ref-type="bibr" rid="b71-ad-9-3-537">71</xref>]/2014</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST3</td>
<td align="center" colspan="1" rowspan="1" valign="top">Cdk-5-MST3-RhoA</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates RhoA-dependent actin dynamics and neuronal migration</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Ultanir et al.[<xref ref-type="bibr" rid="b48-ad-9-3-537">48</xref>]/2014</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST3</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST3-TAO1/2</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Promotes spine synapse development</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Zhou et al.[<xref ref-type="bibr" rid="b24-ad-9-3-537">24</xref>]/2000</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST3b</td>
<td align="center" colspan="1" rowspan="1" valign="top">PKA-MST3b</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates MAPK pathways</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Irwin et al.[<xref ref-type="bibr" rid="b72-ad-9-3-537">72</xref>]/2006</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST3b</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Neurotrophic-MST3b</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Promotes axon outgrowth</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Lorber et al.[<xref ref-type="bibr" rid="b14-ad-9-3-537">14</xref>]/2009</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST3b</td>
<td align="center" colspan="1" rowspan="1" valign="top">/</td>
<td align="center" colspan="1" rowspan="1" valign="top">Promotes axon regeneration</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Fidalgo et al.[<xref ref-type="bibr" rid="b74-ad-9-3-537">74</xref>]/2012</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST4</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST4-ERM</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Prevents oxidative-stress-induced cell death</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Matsuki et al.[<xref ref-type="bibr" rid="b77-ad-9-3-537">77</xref>]/2010</td>
<td align="center" colspan="1" rowspan="1" valign="top">STK25</td>
<td align="center" colspan="1" rowspan="1" valign="top">LKB1-STK25-GM130</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mediates Golgi dispersion, axon specification and dendrite growth</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Zhang et al.[<xref ref-type="bibr" rid="b76-ad-9-3-537">76</xref>]/2012</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">STK25</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">CCM3âSTK25</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Promotes oxidative-stress-induced cell apoptosis</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Matsuki et al.[<xref ref-type="bibr" rid="b79-ad-9-3-537">79</xref>]/2013</td>
<td align="center" colspan="1" rowspan="1" valign="top">STK25</td>
<td align="center" colspan="1" rowspan="1" valign="top">/</td>
<td align="center" colspan="1" rowspan="1" valign="top">Acute inactivation of STK25 instead of constitutive STK25 deficiency disrupts the neuronal migration</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="nt1-ad-9-3-537">
<p>The MST1/2 mainly mediates stress-induced cell death. And the different regulators on the upstream or downstream also was introduced in past. While MST3 or MST3b mainly promoted axon outgrowth through several signaling pathway. MST4 and YSK25 can also mediate stress-induced cell death. Besides, STK25 also can mediate neuronal migration.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>The biological function of MST kinases in central nervous system</title>
<p>MST kinases exist in the mammalian cellular signal transductions to control cell homeostasis and survival involving cell apoptosis, differentiation, migration, and transformation [<xref ref-type="bibr" rid="b7-ad-9-3-537">7</xref>]. Evidence showed MST kinases have essential roles in the immune system [<xref ref-type="bibr" rid="b62-ad-9-3-537">62</xref>, <xref ref-type="bibr" rid="b63-ad-9-3-537">63</xref>], digestive system [<xref ref-type="bibr" rid="b20-ad-9-3-537">20</xref>, <xref ref-type="bibr" rid="b64-ad-9-3-537">64</xref>], cardiovascular system [<xref ref-type="bibr" rid="b65-ad-9-3-537">65</xref>, <xref ref-type="bibr" rid="b66-ad-9-3-537">66</xref>], respiratory system [<xref ref-type="bibr" rid="b38-ad-9-3-537">38</xref>] and CNS. We give an overview of MST kinases and their various roles in CNS function (<xref ref-type="table" rid="T1-ad-9-3-537">Table 1</xref>).</p>
<p>MST1 and MST2 contribute critical roles in regulation of neural cell death. Under oxidative stress stimulation, MST1 is activated in mammalian neurons and catalyze phosphorylation on transcription factor, FOXO3, at serine 207 [<xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>]. It steers the FOXO3 away from the 14-3-3 proteins and aids in its translocation to the nucleus. Accumulation of nuclear FOXO3 induces expression of cell death genes [<xref ref-type="bibr" rid="b36-ad-9-3-537">36</xref>]. Another FOXO family protein FOXO1 can also be phosphorylated by MST1 at serine 212 in granule neurons deprived of growth factors and neuronal activity [<xref ref-type="bibr" rid="b22-ad-9-3-537">22</xref>]. Similarly, it triggers disruption of associations between FOXO1 and 14-3-3 proteins and subsequently leads to cell death [<xref ref-type="bibr" rid="b22-ad-9-3-537">22</xref>]. These two findings demonstrate how MST1-FOXO signaling acts as an important link in the stress-induced neuronal cell death. Protein kinase c-Abl also regulates MST1 by phosphorylating it at Y433 during oxidative stress responses of neurons [<xref ref-type="bibr" rid="b67-ad-9-3-537">67</xref>]. A recent study showed that c-Abl situated upstream of MST1-FOXO3 signaling pathway promotes cell death processes in both rat hippocampal neurons and primary culture neurons [<xref ref-type="bibr" rid="b67-ad-9-3-537">67</xref>]. However, another study suggested a mutual regulatory dynamic mechanism exists between Mst1 and c-Abl under the conditions of oxidative stress in astrocytes [<xref ref-type="bibr" rid="b68-ad-9-3-537">68</xref>]. The zinc-binding protein metallothionein-3 (Mt3) contributes to the activation of c-Abl through its interaction with actin [<xref ref-type="bibr" rid="b69-ad-9-3-537">69</xref>]. MST1 and c-Abl may be regulated by Mt3 by sensing the level of free zinc separated from zinc-Mt3complex after oxidative stress induction [<xref ref-type="bibr" rid="b68-ad-9-3-537">68</xref>]. Recently, MST2 was found to be phosphorylated by c-Abl at Y81, an evolutionarily conserved site within the kinase domain. This reinforced the function of the c-Abl-MST signaling cascade in neuronal cell death after oxidative stress [<xref ref-type="bibr" rid="b25-ad-9-3-537">25</xref>]. Simultaneously, after injury or infection of the CNS, elevated interferon-Î³ (IFN-Î³) can induce expression of the Daxx in microglial cells which are located in macrophages and are first responders to outer stimulation in the brain [<xref ref-type="bibr" rid="b70-ad-9-3-537">70</xref>]. Subsequently, the microglial cells mediate the MST1 activities, such as activation, homodimerization, and nuclear translocation. This mechanism upregulates the IFN-Î³ induced microglial cell death when compared with the MST1-null mice [<xref ref-type="bibr" rid="b70-ad-9-3-537">70</xref>].</p>
<p>MST3, MST4, and YSK1 kinases regulate cell polarity and migration through interaction with different proteins [<xref ref-type="bibr" rid="b11-ad-9-3-537">11</xref>, <xref ref-type="bibr" rid="b42-ad-9-3-537">42</xref>-<xref ref-type="bibr" rid="b44-ad-9-3-537">44</xref>]. MST3 silencing in utero can significantly disrupt the multipolar-to-bipolar transition in the migrating neurons. The serine/threonine kinase, cyclin-dependent kinase 5 (Cdk5) was shown to be the upstream regulator of the MST3 though its phosphorylating effect at Ser79 site of MST3 [<xref ref-type="bibr" rid="b71-ad-9-3-537">71</xref>]. Furthermore, MST3 regulated neuronal migration by phosphorylating the RhoA at Ser26 and modulating its activity with GTP, contributing to actin dynamics in neurons [<xref ref-type="bibr" rid="b71-ad-9-3-537">71</xref>]. A recent study showed MST3 enhances the development of proper filopodia, dendritic spine, and excitatory synapse by phosphorylating the downstream effector TAO1/2, the microtubule and actin interactor binding proteins [<xref ref-type="bibr" rid="b48-ad-9-3-537">48</xref>]. Phosphorylated TAO1/2 subsequently enables Myosin Va function to promote the development of dentridic spine synapse [<xref ref-type="bibr" rid="b48-ad-9-3-537">48</xref>].</p>
<p>MST3b is a special isoform of MST3 kinase, identified and discerned from MST3 in the 5â² coding region. It is mainly expressed in brain regions [<xref ref-type="bibr" rid="b24-ad-9-3-537">24</xref>]. The AMP-dependent protein kinase (PKA) directly phosphorylates the MST3b, but not MST3 at amino terminus Thr-18 to regulate the MAPK pathways [<xref ref-type="bibr" rid="b24-ad-9-3-537">24</xref>]. In addition, it can be activated by neurotrophic factors and promotes axonal outgrowth in neurons, such as adult optic nerve and radial nerve [<xref ref-type="bibr" rid="b14-ad-9-3-537">14</xref>, <xref ref-type="bibr" rid="b72-ad-9-3-537">72</xref>]. However, the potential mechanism that exists between MST3b and axonal outgrowth remains less well understood and requires a further investigation.</p>
<p>CCM3, also called PDCD10 (programmed cell death 10), is closely related to the functions of GCKIII family of protein kinases whose mutation can lead to the development of CCMs in the brain[<xref ref-type="bibr" rid="b73-ad-9-3-537">73</xref>]. The MST4 kinase has the capacity to phosphorylate cytoskeletal proteins, including ezrin/radixin/moesin (ERM) family proteins, in response to the oxidative stress[<xref ref-type="bibr" rid="b74-ad-9-3-537">74</xref>]. Under the normal circumstances, MST4 mainly locates on the cis-Golgi, forming a complex with GM130 in unstressed cells. However, MST4 is activated by the CCM3 after exposure to reactive oxygen species and executes a prosurvival role to face cell death [<xref ref-type="bibr" rid="b75-ad-9-3-537">75</xref>]. Another GCKIII family member STK25 (namely YSK1) is also activated under stimulation of oxidative stress. The interaction between STK25 and CCM3 further regulates the extracellular signal-regulated kinase. This reaction aggravates the cell apoptosis [<xref ref-type="bibr" rid="b76-ad-9-3-537">76</xref>]. STK25 overexpression promotes Golgi condensation and multiple axons with the assistance of protein kinase LKB1 in the nervous system [<xref ref-type="bibr" rid="b77-ad-9-3-537">77</xref>]. Interestingly, the LKB1-STK25-GM130 signaling parallels with the Reelin-Dab1 signaling and presents an antagonistic phenomenon on neural polarization, morphogenesis, and Golgi distribution [<xref ref-type="bibr" rid="b77-ad-9-3-537">77</xref>]. The Reelin-Dab1 signal pathway is responsible for the cell positioning, synaptic circuit formation, and neuronal migration during development of the CNS [<xref ref-type="bibr" rid="b78-ad-9-3-537">78</xref>]. However, it is unknown whether STK25 affects neuronal migration and involves the Reelin pathway. The following study found that acute inactivation of the STK25 can disrupt the neuronal migration instead of constitutive STK25 deficiency. In addition, LKB1, STRAD and GM130 also take part in this process [<xref ref-type="bibr" rid="b79-ad-9-3-537">79</xref>]. Despite the current understanding, details on how these proteins interact to regulate neuronal migration during development is a topic for future studies.</p>
</sec>
<sec>
<title>The MST kinases in central nervous system disorders Brain Tumor</title>
<p>As discussed above, the MST1/2-Lats-YAP/TAZ signaling pathway has potent effects on regulating cell proliferation, and was accepted as a potential mechanism of tumor growth. The evidence shows that down-regulated MST1 expression can be a tumor growth marker of colorectal cancer or lymphoma/leukemia[<xref ref-type="bibr" rid="b80-ad-9-3-537">80</xref>, <xref ref-type="bibr" rid="b81-ad-9-3-537">81</xref>]. Decreased Lats level can be observed in the breast cancers and mesotheliomas [<xref ref-type="bibr" rid="b82-ad-9-3-537">82</xref>, <xref ref-type="bibr" rid="b83-ad-9-3-537">83</xref>]. While up-regulated YAP/TAZ expression has also been demonstrated taking parts in cancer development, such as lung cancer [<xref ref-type="bibr" rid="b84-ad-9-3-537">84</xref>], hepatocellular carcinoma [<xref ref-type="bibr" rid="b85-ad-9-3-537">85</xref>], colorectal cancer [<xref ref-type="bibr" rid="b86-ad-9-3-537">86</xref>], pancreatic ductal[<xref ref-type="bibr" rid="b84-ad-9-3-537">84</xref>], medullablastoma [<xref ref-type="bibr" rid="b82-ad-9-3-537">82</xref>] and neurofibromatosis type2 [<xref ref-type="bibr" rid="b87-ad-9-3-537">87</xref>]. Meanwhile, this phenomenon was also detected in cerebral malignant tumor at the mRNA and protein levels. Moreover, they found new evidence that YAP/TAZ can abnormally activate the target gene, BIRC5, accompanied with down-regulation of LATS1/2, in turn simulating aberrant cell growth and neoplasia in glioblastoma [<xref ref-type="bibr" rid="b88-ad-9-3-537">88</xref>]. However, the upstream regulator of MST1/2-Lats-YAP/TAZ signaling pathway remains unknown in their study. MicroRNAs (miRNAs) are critical components in human tumorigenesis with the assistance of their mRNA 3â² untranslated regions [<xref ref-type="bibr" rid="b89-ad-9-3-537">89</xref>, <xref ref-type="bibr" rid="b90-ad-9-3-537">90</xref>]. Recently, a study found that miR-130b, situated upstream of MST1/2-Lats-YAP/TAZ, was substantially overexpressed in human glioblastoma growth. Hyperactivation of miR-130b directly suppressed MST1 activity, further leading to YAP/TAZ activation [<xref ref-type="bibr" rid="b91-ad-9-3-537">91</xref>].</p>
<p>The survival kinase AKT is located downstream of the phosphatidylinositol 3-kinase (PI3K), is constitutively activated and regulates human cancer and precancerosis progression [<xref ref-type="bibr" rid="b92-ad-9-3-537">92</xref>-<xref ref-type="bibr" rid="b94-ad-9-3-537">94</xref>]. It has been shown this mechanism also functions through signaling between AKT and downstream mammalian target rapamycin (mTOR) [<xref ref-type="bibr" rid="b95-ad-9-3-537">95</xref>, <xref ref-type="bibr" rid="b96-ad-9-3-537">96</xref>]. Similarly, another study found MST1 binds to AKT and attenuated the AKT and mTOR activity in glioma cell. This finding further suggested that MST1-AKT-mTOR signaling pathway is involved in glioma cell proliferation and growth. However, YAP expression was not affected in this study [<xref ref-type="bibr" rid="b97-ad-9-3-537">97</xref>].</p>
<p>Although MST3 and MST4 have rarely been introduced in tumorigenesis, they may play a positive role in tumorigenesis due to the function of cell migration. Studies found that rising MST4 and CCM3 expression level increases breast cancer progression and poor prognoses [<xref ref-type="bibr" rid="b45-ad-9-3-537">45</xref>, <xref ref-type="bibr" rid="b98-ad-9-3-537">98</xref>]. While the involvement of MST3/4 in CNS tumorigenesis still needs further investigation, another GCKIII family member, STK25, was shown to mediate TrkA-CCM2 death signaling in medulloblastoma cells [<xref ref-type="bibr" rid="b99-ad-9-3-537">99</xref>]. The TrkA regulates tumor cell death in neuroblastoma via its interaction with protein product of CCM2 [<xref ref-type="bibr" rid="b100-ad-9-3-537">100</xref>]. Subsequent findings show that STK25 can phosphorylate CCM2 and initiate death signaling in medulloblastoma cells [<xref ref-type="bibr" rid="b99-ad-9-3-537">99</xref>].</p>
</sec>
<sec>
<title>Cerebrovascular Diseases</title>
<p>Cerebrovascular diseases include cerebral hemorrhage, ischemic, arterial or venous malformations, or other vascular lesions [<xref ref-type="bibr" rid="b101-ad-9-3-537">101</xref>]. Death from stoke is three times more likely than death from coronary cardiovascular diseases in China [<xref ref-type="bibr" rid="b102-ad-9-3-537">102</xref>]. The most common disease concerning MST kinases is CCM, which can change neurological function via hemorrhage, vascular steal, venous congestion, or compression effect on normal brain tissue [<xref ref-type="bibr" rid="b103-ad-9-3-537">103</xref>]. Disorders in the signaling pathways of MST3, MST4, and STK25 are the widely accepted factor in CCM pathology [<xref ref-type="bibr" rid="b18-ad-9-3-537">18</xref>, <xref ref-type="bibr" rid="b104-ad-9-3-537">104</xref>]. The CCM gene family includes CCM1, CCM2, and CCM3. The clinical manifestations of patients suffering genetic mutations of these three genes are similar, suggesting a common pathway integrated with their expression [<xref ref-type="bibr" rid="b105-ad-9-3-537">105</xref>]. Previous studies demonstrated that STK24 and STK25 interact with CCM3, but only STK25 has the ability to phosphorylate CCM3 [<xref ref-type="bibr" rid="b75-ad-9-3-537">75</xref>, <xref ref-type="bibr" rid="b106-ad-9-3-537">106</xref>]. STK25 forms a protein complex with CCM2 [<xref ref-type="bibr" rid="b106-ad-9-3-537">106</xref>]. However, the specific mechanism and potential relationship between STK25, CCM2, and CCM3 remains vague. This link between CCM2, CCM3, and STK25 can be the essential part of signaling pathways in CCM pathogenesis. A recent study proposed that STK24 and STK25 control endothelial cell-cell junctions through directly activating ERM family protein, which negatively regulates Rho. They speculated that the CCM3/STK signaling may share a common pathway with STK/ERM/Rho signaling to regulate epithelial and endothelial cell junctions. This is essential in cardiovascular development and diseases such as CCM [<xref ref-type="bibr" rid="b104-ad-9-3-537">104</xref>]. While it is obvious that GCKIII family proteins widely participate in endothelial pathologies, more work is required to effectively elaborate on the exact relationship between GCKIII family proteins and CCMs.</p>
<p>Cerebral ischemia is the main cause of strokes, accounting for 80% of cerebrovascular accidents [<xref ref-type="bibr" rid="b107-ad-9-3-537">107</xref>]. It causes the highest rate of disability, is the second cause of dementia, and the fourth cause of death in development countries [<xref ref-type="bibr" rid="b107-ad-9-3-537">107</xref>]. A recent study demonstrated that MST1 signaling is important for oxidative stress-induced neuronal cell death after cerebral ischemia via microglial activation [<xref ref-type="bibr" rid="b108-ad-9-3-537">108</xref>]. Microglial activation is an important step in ischemic stroke-induced immune alteration and essential for oxidative stress-induced neuronal cell death [<xref ref-type="bibr" rid="b109-ad-9-3-537">109</xref>, <xref ref-type="bibr" rid="b110-ad-9-3-537">110</xref>]. A recent study demonstrated that MST1 regulates microglial activation via directly phosphorylating substrate protein IÎºBÎ± and subsequently initiating the nuclear factor-kappa B (NF-Îºb) activation. NF-Îºb is thought to delayed inflammation and neurotoxicity in microglia [<xref ref-type="bibr" rid="b108-ad-9-3-537">108</xref>, <xref ref-type="bibr" rid="b111-ad-9-3-537">111</xref>]. Upstream kinase Src was was showed to regulate MST1-IÎºB signaling during microglial activation. This novel pathway is a potent therapeutic target for ischemic stroke[<xref ref-type="bibr" rid="b108-ad-9-3-537">108</xref>]. Furthermore, another study found the Hopeahainanensis leaf extract oligomer compound, Malibatol A, can prevent oxygen-glucose deprivation (OGD) induced BV2 cell injury via the potential c-Abl/MST1 signaling pathway [<xref ref-type="bibr" rid="b112-ad-9-3-537">112</xref>]. The BV2 cell is the common alternative candidate of microglia, as it is similar in morphology, phenotypes and functions [<xref ref-type="bibr" rid="b113-ad-9-3-537">113</xref>]. The balance between M1 and M2 microglia marker of BV2 cell was modulated by Malibatol A which effectively attenuated cell injury after OGD stimulation [<xref ref-type="bibr" rid="b112-ad-9-3-537">112</xref>]. This balance is crucial for improving neurological disease outcomes [<xref ref-type="bibr" rid="b114-ad-9-3-537">114</xref>]. Despite enhanced expression of p-MST1 and c-Abls after OGD, with a parallel phenomenon of shifting M1 microglia to M2 microglia, the detailed relationship requires further investigation.</p>
<table-wrap id="T2-ad-9-3-537" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p>The MST kinases in CNS diseases.</p>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="background-color:#63B2DE" valign="top"></th>
<th align="left" colspan="1" rowspan="1" style="background-color:#63B2DE" valign="top">Author/year</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#63B2DE" valign="top">Disease</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#63B2DE" valign="top">MST kinase</th>
<th align="left" colspan="1" rowspan="1" style="background-color:#63B2DE" valign="top">Main finding</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="4" valign="middle">Tumor</td>
<td align="center" colspan="1" rowspan="1" valign="top">Costa et al.[<xref ref-type="bibr" rid="b99-ad-9-3-537">99</xref>]<break></break>/2012</td>
<td align="center" colspan="1" rowspan="1" valign="top">Medulloblastoma</td>
<td align="center" colspan="1" rowspan="1" valign="top">STK25</td>
<td align="center" colspan="1" rowspan="1" valign="top">STK25 prevents medulloblastoma cells death via attenuating TrkAâSTK25 signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Chao et al. [<xref ref-type="bibr" rid="b97-ad-9-3-537">97</xref>]<break></break>/2015</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Mst1 prevents glioblastoma growth via attenuating AKTâmTOR signaling pathway</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Zhu et al.[<xref ref-type="bibr" rid="b91-ad-9-3-537">91</xref>]<break></break>/2015</td>
<td align="center" colspan="1" rowspan="1" valign="top">Glioblastoma</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1/2</td>
<td align="center" colspan="1" rowspan="1" valign="top">miR-130b promotes glioblastoma growth via attenuating MST1/2âLatsâYAP/TAZ signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Zhang et al.[<xref ref-type="bibr" rid="b88-ad-9-3-537">88</xref>]<break></break>/2016</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1/2</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">YAP/TAZâBIRC5 signaling pathway induced by Lats down-regulation promotes glioblastoma growth</td>
</tr>
<tr>
<td colspan="1" rowspan="5" valign="middle">Vascular diseases</td>
<td align="center" colspan="1" rowspan="1" valign="top">Voss et al.[<xref ref-type="bibr" rid="b106-ad-9-3-537">106</xref>]<break></break>/2007</td>
<td align="center" colspan="1" rowspan="1" valign="top">CCM</td>
<td align="center" colspan="1" rowspan="1" valign="top">STK25</td>
<td align="center" colspan="1" rowspan="1" valign="top">Interaction between CCM2, CCM3 and STK25 mediates vascular development and CCM pathogenesis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Zheng et al.[<xref ref-type="bibr" rid="b104-ad-9-3-537">104</xref>]<break></break>/2010</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">CCM</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">STK24/25</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Interaction between CCMs and STKs mediates vascular development and CCM pathogenesis</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Zhao et al.[<xref ref-type="bibr" rid="b108-ad-9-3-537">108</xref>]<break></break>/2016</td>
<td align="center" colspan="1" rowspan="1" valign="top">Cerebral ischemia</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1 promotes cerebral-ischemia-induced microglia activation via SrcâMST1âIÎºBÎ± signaling pathway</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Weng et al.[<xref ref-type="bibr" rid="b112-ad-9-3-537">112</xref>]<break></break>/2016</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Cerebral ischemia</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Malibatol A prevents cerebral-ischemia-induced microglia activation via c-AblâMST1 signaling pathway</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Yang et al.[<xref ref-type="bibr" rid="b115-ad-9-3-537">115</xref>]<break></break>/2016</td>
<td align="center" colspan="1" rowspan="1" valign="top">VD</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">TSL protects neurons activity in VD via attenuating inflammatory reaction mediated by MST1âFOXO3 signaling pathway</td>
</tr>
<tr>
<td colspan="1" rowspan="3" valign="middle">Neurodegenerative diseases</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Matsuki et al.[<xref ref-type="bibr" rid="b23-ad-9-3-537">23</xref>]<break></break>/2012</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">AD</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">STK25</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Stk25 attenuating AD development via preventing Tau phosphorylation induced by Dab1 deficiency</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="top">Lee et al.[<xref ref-type="bibr" rid="b130-ad-9-3-537">130</xref>]<break></break>/2013</td>
<td align="center" colspan="1" rowspan="1" valign="top">ALS</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST1 mediates ALS development via interaction with SOD1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Pan et al.[<xref ref-type="bibr" rid="b138-ad-9-3-537">138</xref>]/2014</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Prion diseases</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">MST1</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">c-AblâMST1 signaling pathway promotes prion-induced neuralapoptosisin Prion diseases</td>
</tr>
<tr>
<td colspan="1" rowspan="2" valign="middle">Other CNS diseases</td>
<td align="center" colspan="1" rowspan="1" valign="top">Zhang et al.[<xref ref-type="bibr" rid="b142-ad-9-3-537">142</xref>]/2015</td>
<td align="center" colspan="1" rowspan="1" valign="top">Spine injury</td>
<td align="center" colspan="1" rowspan="1" valign="top">MST3b</td>
<td align="center" colspan="1" rowspan="1" valign="top">Mst3b promotes neural regeneration in injured spinal cord</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">Imitola et al.[<xref ref-type="bibr" rid="b13-ad-9-3-537">13</xref>]/2015</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">2q37 microdeletion syndrome</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">STK25</td>
<td align="left" colspan="1" rowspan="1" style="background-color:#E8EEF0" valign="top">STK25 deletion was the most interacting gene in neural development disorder of 2q37 microdeletion syndrome</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="nt2-ad-9-3-537">
<p>The MST-related CNS diseases in four parts: tumor, vascular, neurodegenerative diseases and other CNS diseases. The study of multiple MST signaling pathways might provide us better therapeutic targets for the treatment of CNS diseases.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>MST1 is also involved in the development of vascular dementia (VD) through the MST1-FOXO3 signaling pathway [<xref ref-type="bibr" rid="b115-ad-9-3-537">115</xref>]. VD is a common age-related neural disease, usually a result of cerebrovascular disease, such as ischemic or hemorrhagic stroke [<xref ref-type="bibr" rid="b116-ad-9-3-537">116</xref>]. The inflammation cascade is triggered by these cerebrovascular events, and the secondary inflammatory response initiates blood-brain barrier dysfunction, cerebral edema, and neuronal cell death [<xref ref-type="bibr" rid="b117-ad-9-3-537">117</xref>-<xref ref-type="bibr" rid="b119-ad-9-3-537">119</xref>]. These alterations play an important role in pathological development of VD [<xref ref-type="bibr" rid="b120-ad-9-3-537">120</xref>, <xref ref-type="bibr" rid="b121-ad-9-3-537">121</xref>]. As previous discussed, the MST1-FOXO3 signaling pathway mediates oxidative stress-induced neuronal cell death [<xref ref-type="bibr" rid="b67-ad-9-3-537">67</xref>]. Intresetingly, a recent study presented how Tanshinol (TSL),a traditional Chinese medicine for vascular disease, can protect the hippocampus and prevent learning and memory impairment via attenuatingMST1-FOXO3 signaling meditaed inflammatory process in a rat model of VD [<xref ref-type="bibr" rid="b115-ad-9-3-537">115</xref>].</p>
</sec>
<sec>
<title>Neurodegenerative diseases</title>
<p>MST kinases are involved in neurodegenerative diseases including Alzheimerâs disease (AD) and Amyotrophic lateral sclerosis (ALS). AD is the most common neurodegenerative disease. However, the mechanisms behind AD remain unclear [<xref ref-type="bibr" rid="b122-ad-9-3-537">122</xref>, <xref ref-type="bibr" rid="b123-ad-9-3-537">123</xref>]. Excessive binding protein Tau phosphorylation is wildly accepted as a feature of AD, Parkinsonâs, and Frontal Temporal Lobe Dementia [<xref ref-type="bibr" rid="b124-ad-9-3-537">124</xref>, <xref ref-type="bibr" rid="b125-ad-9-3-537">125</xref>]. Docking protein Dab1 deficiency in Reelin signaling pathway can lead to Tau hyperphosphorylation. However, the physiological function of STK25 (performs neuronal polarization regulation and Golgi morphology) was found to have the ability to defend against the Dab1 effect in development of AD in rat model, demonstrating the anti-AD effect of STK25 [<xref ref-type="bibr" rid="b23-ad-9-3-537">23</xref>]. Thus, the investigation of STK25 in AD is a topic of interest in AD treatment.</p>
<p>ALS is an adult neurodegenerative disease featured by the progressive loss of motor neurons in the motor cortex, brainstem, and spinal cord [<xref ref-type="bibr" rid="b126-ad-9-3-537">126</xref>, <xref ref-type="bibr" rid="b127-ad-9-3-537">127</xref>]. Mutants of human superoxide dismutase 1 (SOD1) gene, which usually causes oxidative damage and apoptosis in motor neurons, and are the most acceptable mechanism of ALS pathogenesis [<xref ref-type="bibr" rid="b128-ad-9-3-537">128</xref>, <xref ref-type="bibr" rid="b129-ad-9-3-537">129</xref>]. The recent study found that genetic ablation of MST1 can delay ALS onset and improve prognosis in human SOD1(G93A) mutant mice [<xref ref-type="bibr" rid="b130-ad-9-3-537">130</xref>]. As previously mentioned, the redox protein thioredoxin-1 (Trx1) inhibits MST1 homodimerization and autophosphorylation after oxidative induction [<xref ref-type="bibr" rid="b131-ad-9-3-537">131</xref>]. SOD1(G93A) reversed this process and promoted MST1 activation. Furthermore, SOD1(G93A) induced activation of p38 MAPK and caspases and abnormalities in autophagic flux formation, thereby contributing to the pathogenesis of ALS [<xref ref-type="bibr" rid="b130-ad-9-3-537">130</xref>, <xref ref-type="bibr" rid="b132-ad-9-3-537">132</xref>-<xref ref-type="bibr" rid="b134-ad-9-3-537">134</xref>].</p>
<p>Other MST kinases related neurodegenerative disorders are Prion diseases, characterized by the accumulation of a disease-associated abnormal prion protein and neuron apoptosis [<xref ref-type="bibr" rid="b135-ad-9-3-537">135</xref>]. Evidence demonstrated oxidative induction is the main contributor to Prion diseases pathogenesis. This was proved by the PrP106-126 or PrP<sup>Sc</sup> model, a common model system to study prion-induced neurodegeneration [<xref ref-type="bibr" rid="b136-ad-9-3-537">136</xref>, <xref ref-type="bibr" rid="b137-ad-9-3-537">137</xref>]. PrP106-126 activates c-Abl and subsequently upregulates MST1 and pro-apoptotic gene BIM, leading to neuron apoptosis via mitochondrial dysfunction [<xref ref-type="bibr" rid="b138-ad-9-3-537">138</xref>].</p>
</sec>
<sec>
<title>Other CNS diseases</title>
<p>Spinal cord injury is a devastating neurological diseases associated with high morbidity and functional impairments impacting quality of life [<xref ref-type="bibr" rid="b139-ad-9-3-537">139</xref>-<xref ref-type="bibr" rid="b141-ad-9-3-537">141</xref>]. MST3b is activated by neurotrophic factors and promotes axon outgrowth in damaged adult optic nerve and radial nerve [<xref ref-type="bibr" rid="b14-ad-9-3-537">14</xref>, <xref ref-type="bibr" rid="b72-ad-9-3-537">72</xref>]. Moreover, it was found that Mst3b also plays an important role in injured spinal cord neurons. Increased MST3b levels can facilitate axonal regeneration of spinal cord neurons in vivo and in vitro. MST3b interacts with small G protein Ras and MAPK kinase, promoting down-stream signaling pathways, including P42/44<sup>MAPK</sup> and LIMK/Cofilin signaling pathway, which further modulates actin cytoskeleton, resulting in axon regeneration in spinal cord neurons [<xref ref-type="bibr" rid="b142-ad-9-3-537">142</xref>].</p>
<p>The 2q37 microdeletion syndrome is a syndrome characterized by mild-moderate developmental or intellectual disability, abnormal short bones in the fingers and hands, obesity, special facial appearance, autism and lot CNS disorders, including seizures and hydrocephalus [<xref ref-type="bibr" rid="b143-ad-9-3-537">143</xref>]. The loss of approximately 100 genes loss in the 2q37 band is the main cause of this syndrome. However, the definite phenotype in this type of gene deletion is still unknown [<xref ref-type="bibr" rid="b144-ad-9-3-537">144</xref>]. A recent study suggested STK25 deletion was the important gene deletion contributing to the neural developmental disorders associated with this syndrome. It broadens our understanding on the causative genomic region of 2q37 microdeletion syndrome and gives us a specific gene regarding the development of the human cortex and corpus callosum [<xref ref-type="bibr" rid="b13-ad-9-3-537">13</xref>] (<xref ref-type="table" rid="T2-ad-9-3-537">Table 2</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>MST kinases are an essential part the signaling transduction pathways, maintaining numerous biological functions, such as controlling cell growth, cell migration, cell polarity and cell apoptosis. The regulation of MST kinases is complicated and current studies on the regulatory mechanisms are not well understood. Accumulating evidence suggests MST kinases have essential roles in different body systems. They are also important to the CNS when it comes to biological function and development of disease. Increasing investigation and understanding of MST signaling pathways including regulatory and pathological processes of MST kinases and their role in the CNS could provide the research and medical community with new therapeutic targets for human diseases.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was supported by the National Natural Science Foundation of China (81500992), Natural Science Foundation of Zhejiang (LQ16H090002), Medical and health key project of Zhejiang Province (2016RCA015).</p>
</ack>
<fn-group>
<fn fn-type="COI-statement" id="fn2-ad-9-3-537">
<p>
<bold>Conflict of Interest</bold>
</p>
<p>The authors report no conflict of interest concerning the materials used in this study or findings specified in this paper.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-ad-9-3-537">
<label>[1]</label>
<mixed-citation publication-type="journal"><name><surname>Seger</surname><given-names>R</given-names></name>, <name><surname>Krebs</surname><given-names>EG</given-names></name> (<year>1995</year>). <article-title>The MAPK signaling cascade</article-title>. <source/>FASEB J, <volume>9</volume>: <fpage>726</fpage>-<lpage>735</lpage><pub-id pub-id-type="pmid">7601337</pub-id></mixed-citation>
</ref>
<ref id="b2-ad-9-3-537">
<label>[2]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>YJ</given-names></name>, <name><surname>Kim</surname><given-names>MH</given-names></name>, <name><surname>Kwak</surname><given-names>JM</given-names></name> (<year>2016</year>). <article-title>MAPK Cascades in Guard Cell Signal Transduction</article-title>. <source/>Front Plant Sci, <volume>7</volume>: <fpage>80</fpage><pub-id pub-id-type="pmid">26904052</pub-id></mixed-citation>
</ref>
<ref id="b3-ad-9-3-537">
<label>[3]</label>
<mixed-citation publication-type="journal"><name><surname>Manning</surname><given-names>G</given-names></name>, <name><surname>Whyte</surname><given-names>DB</given-names></name>, <name><surname>Martinez</surname><given-names>R</given-names></name>, <name><surname>Hunter</surname><given-names>T</given-names></name>, <name><surname>Sudarsanam</surname><given-names>S</given-names></name> (<year>2002</year>). <article-title>The protein kinase complement of the human genome</article-title>. <source/>Science, <volume>298</volume>: <fpage>1912</fpage>-<lpage>1934</lpage><pub-id pub-id-type="pmid">12471243</pub-id></mixed-citation>
</ref>
<ref id="b4-ad-9-3-537">
<label>[4]</label>
<mixed-citation publication-type="journal"><name><surname>Ramer</surname><given-names>SW</given-names></name>, <name><surname>Davis</surname><given-names>RW</given-names></name> (<year>1993</year>). <article-title>A dominant truncation allele identifies a gene, STE20, that encodes a putative protein kinase necessary for mating in Saccharomyces cerevisiae</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>90</volume>: <fpage>452</fpage>-<lpage>456</lpage><pub-id pub-id-type="pmid">8421676</pub-id></mixed-citation>
</ref>
<ref id="b5-ad-9-3-537">
<label>[5]</label>
<mixed-citation publication-type="journal"><name><surname>Hofmann</surname><given-names>C</given-names></name>, <name><surname>Shepelev</surname><given-names>M</given-names></name>, <name><surname>Chernoff</surname><given-names>J</given-names></name> (<year>2004</year>). <article-title>The genetics of Pak</article-title>. <source/>J Cell Sci, <volume>117</volume>: <fpage>4343</fpage>-<lpage>4354</lpage><pub-id pub-id-type="pmid">15331659</pub-id></mixed-citation>
</ref>
<ref id="b6-ad-9-3-537">
<label>[6]</label>
<mixed-citation publication-type="journal"><name><surname>Strange</surname><given-names>K</given-names></name>, <name><surname>Denton</surname><given-names>J</given-names></name>, <name><surname>Nehrke</surname><given-names>K</given-names></name> (<year>2006</year>). <article-title>Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell volume</article-title>. <source/>Physiology (Bethesda), <volume>21</volume>: <fpage>61</fpage>-<lpage>68</lpage><pub-id pub-id-type="pmid">16443823</pub-id></mixed-citation>
</ref>
<ref id="b7-ad-9-3-537">
<label>[7]</label>
<mixed-citation publication-type="journal"><name><surname>Ling</surname><given-names>P</given-names></name>, <name><surname>Lu</surname><given-names>TJ</given-names></name>, <name><surname>Yuan</surname><given-names>CJ</given-names></name>, <name><surname>Lai</surname><given-names>MD</given-names></name> (<year>2008</year>). <article-title>Biosignaling of mammalian Ste20-related kinases</article-title>. <source/>Cell Signal, <volume>20</volume>: <fpage>1237</fpage>-<lpage>1247</lpage><pub-id pub-id-type="pmid">18255267</pub-id></mixed-citation>
</ref>
<ref id="b8-ad-9-3-537">
<label>[8]</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>D</given-names></name> (<year>2010</year>). <article-title>The hippo signaling pathway in development and cancer</article-title>. <source/>Dev Cell, <volume>19</volume>: <fpage>491</fpage>-<lpage>505</lpage><pub-id pub-id-type="pmid">20951342</pub-id></mixed-citation>
</ref>
<ref id="b9-ad-9-3-537">
<label>[9]</label>
<mixed-citation publication-type="journal"><name><surname>Varelas</surname><given-names>X</given-names></name> (<year>2014</year>). <article-title>The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease</article-title>. <source/>Development, <volume>141</volume>: <fpage>1614</fpage>-<lpage>1626</lpage><pub-id pub-id-type="pmid">24715453</pub-id></mixed-citation>
</ref>
<ref id="b10-ad-9-3-537">
<label>[10]</label>
<mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>FX</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2015</year>). <article-title>Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer</article-title>. <source/>Cell, <volume>163</volume>: <fpage>811</fpage>-<lpage>828</lpage><pub-id pub-id-type="pmid">26544935</pub-id></mixed-citation>
</ref>
<ref id="b11-ad-9-3-537">
<label>[11]</label>
<mixed-citation publication-type="journal"><name><surname>Preisinger</surname><given-names>C</given-names></name>, <name><surname>Short</surname><given-names>B</given-names></name>, <name><surname>De Corte</surname><given-names>V</given-names></name>, <name><surname>Bruyneel</surname><given-names>E</given-names></name>, <name><surname>Haas</surname><given-names>A</given-names></name>, <name><surname>Kopajtich</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2004</year>). <article-title>YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3zeta</article-title>. <source/>J Cell Biol, <volume>164</volume>: <fpage>1009</fpage>-<lpage>1020</lpage><pub-id pub-id-type="pmid">15037601</pub-id></mixed-citation>
</ref>
<ref id="b12-ad-9-3-537">
<label>[12]</label>
<mixed-citation publication-type="journal"><name><surname>Fitch</surname><given-names>MT</given-names></name>, <name><surname>Silver</surname><given-names>J</given-names></name> (<year>2008</year>). <article-title>CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure</article-title>. <source/>Exp Neurol, <volume>209</volume>: <fpage>294</fpage>-<lpage>301</lpage><pub-id pub-id-type="pmid">17617407</pub-id></mixed-citation>
</ref>
<ref id="b13-ad-9-3-537">
<label>[13]</label>
<mixed-citation publication-type="journal"><name><surname>Imitola</surname><given-names>J</given-names></name>, <name><surname>Khurana</surname><given-names>DS</given-names></name>, <name><surname>Teplyuk</surname><given-names>NM</given-names></name>, <name><surname>Zucker</surname><given-names>M</given-names></name>, <name><surname>Jethva</surname><given-names>R</given-names></name>, <name><surname>Legido</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>A novel 2q37 microdeletion containing human neural progenitors genes including STK25 results in severe developmental delay, epilepsy, and microcephaly</article-title>. <source/>Am J Med Genet A, <volume>167A</volume>: <fpage>2808</fpage>-<lpage>2816</lpage><pub-id pub-id-type="pmid">26238961</pub-id></mixed-citation>
</ref>
<ref id="b14-ad-9-3-537">
<label>[14]</label>
<mixed-citation publication-type="journal"><name><surname>Lorber</surname><given-names>B</given-names></name>, <name><surname>Howe</surname><given-names>ML</given-names></name>, <name><surname>Benowitz</surname><given-names>LI</given-names></name>, <name><surname>Irwin</surname><given-names>N</given-names></name> (<year>2009</year>). <article-title>Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways</article-title>. <source/>Nat Neurosci, <volume>12</volume>: <fpage>1407</fpage>-<lpage>1414</lpage><pub-id pub-id-type="pmid">19855390</pub-id></mixed-citation>
</ref>
<ref id="b15-ad-9-3-537">
<label>[15]</label>
<mixed-citation publication-type="journal"><name><surname>Tam</surname><given-names>RY</given-names></name>, <name><surname>Fuehrmann</surname><given-names>T</given-names></name>, <name><surname>Mitrousis</surname><given-names>N</given-names></name>, <name><surname>Shoichet</surname><given-names>MS</given-names></name> (<year>2014</year>). <article-title>Regenerative therapies for central nervous system diseases: a biomaterials approach</article-title>. <source/>Neuropsychopharmacology, <volume>39</volume>: <fpage>169</fpage>-<lpage>188</lpage><pub-id pub-id-type="pmid">24002187</pub-id></mixed-citation>
</ref>
<ref id="b16-ad-9-3-537">
<label>[16]</label>
<mixed-citation publication-type="journal"><name><surname>Bramlett</surname><given-names>HM</given-names></name> (<year>2013</year>). <article-title>Special issue of translational stroke: importance of sex in the pathophysiology and treatment of acute CNS repair</article-title>. <source/>Transl Stroke Res, <volume>4</volume>: <fpage>379</fpage>-<lpage>380</lpage><pub-id pub-id-type="pmid">24323336</pub-id></mixed-citation>
</ref>
<ref id="b17-ad-9-3-537">
<label>[17]</label>
<mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>D</given-names></name>, <name><surname>Conrad</surname><given-names>C</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Park</surname><given-names>JS</given-names></name>, <name><surname>Payer</surname><given-names>B</given-names></name>, <name><surname>Yin</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene</article-title>. <source/>Cancer Cell, <volume>16</volume>: <fpage>425</fpage>-<lpage>438</lpage><pub-id pub-id-type="pmid">19878874</pub-id></mixed-citation>
</ref>
<ref id="b18-ad-9-3-537">
<label>[18]</label>
<mixed-citation publication-type="journal"><name><surname>Stockton</surname><given-names>RA</given-names></name>, <name><surname>Shenkar</surname><given-names>R</given-names></name>, <name><surname>Awad</surname><given-names>IA</given-names></name>, <name><surname>Ginsberg</surname><given-names>MH</given-names></name> (<year>2010</year>). <article-title>Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity</article-title>. <source/>J Exp Med, <volume>207</volume>: <fpage>881</fpage>-<lpage>896</lpage><pub-id pub-id-type="pmid">20308363</pub-id></mixed-citation>
</ref>
<ref id="b19-ad-9-3-537">
<label>[19]</label>
<mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>D</given-names></name>, <name><surname>Medoff</surname><given-names>BD</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>XF</given-names></name>, <name><surname>Praskova</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2008</year>). <article-title>The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>105</volume>: <fpage>20321</fpage>-<lpage>20326</lpage><pub-id pub-id-type="pmid">19073936</pub-id></mixed-citation>
</ref>
<ref id="b20-ad-9-3-537">
<label>[20]</label>
<mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>H</given-names></name>, <name><surname>Barry</surname><given-names>E</given-names></name>, <name><surname>Yin</surname><given-names>Y</given-names></name>, <name><surname>Lawrence</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>108</volume>: <fpage>E1312</fpage>-<lpage>1320</lpage><pub-id pub-id-type="pmid">22042863</pub-id></mixed-citation>
</ref>
<ref id="b21-ad-9-3-537">
<label>[21]</label>
<mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>T</given-names></name>, <name><surname>Zhou</surname><given-names>D</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Singh</surname><given-names>T</given-names></name>, <name><surname>Penzo-Mendez</surname><given-names>A</given-names></name>, <name><surname>Maddipati</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Hippo signaling regulates differentiation and maintenance in the exocrine pancreas</article-title>. <source/>Gastroenterology, <volume>144</volume>: <fpage>1543</fpage>-<lpage>1553</lpage>, <fpage>1553 e1541</fpage><pub-id pub-id-type="pmid">23454691</pub-id></mixed-citation>
</ref>
<ref id="b22-ad-9-3-537">
<label>[22]</label>
<mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>Z</given-names></name>, <name><surname>Lehtinen</surname><given-names>MK</given-names></name>, <name><surname>Merlo</surname><given-names>P</given-names></name>, <name><surname>Villen</surname><given-names>J</given-names></name>, <name><surname>Gygi</surname><given-names>S</given-names></name>, <name><surname>Bonni</surname><given-names>A</given-names></name> (<year>2009</year>). <article-title>Regulation of neuronal cell death by MST1-FOXO1 signaling</article-title>. <source/>J Biol Chem, <volume>284</volume>: <fpage>11285</fpage>-<lpage>11292</lpage><pub-id pub-id-type="pmid">19221179</pub-id></mixed-citation>
</ref>
<ref id="b23-ad-9-3-537">
<label>[23]</label>
<mixed-citation publication-type="journal"><name><surname>Matsuki</surname><given-names>T</given-names></name>, <name><surname>Zaka</surname><given-names>M</given-names></name>, <name><surname>Guerreiro</surname><given-names>R</given-names></name>, <name><surname>van der Brug</surname><given-names>MP</given-names></name>, <name><surname>Cooper</surname><given-names>JA</given-names></name>, <name><surname>Cookson</surname><given-names>MR</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice</article-title>. <source/>PLoS One, <volume>7</volume>: <fpage>e31152</fpage><pub-id pub-id-type="pmid">22355340</pub-id></mixed-citation>
</ref>
<ref id="b24-ad-9-3-537">
<label>[24]</label>
<mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>TH</given-names></name>, <name><surname>Ling</surname><given-names>K</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>H</given-names></name>, <name><surname>Wu</surname><given-names>YL</given-names></name>, <name><surname>Jing</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2000</year>). <article-title>Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase</article-title>. <source/>J Biol Chem, <volume>275</volume>: <fpage>2513</fpage>-<lpage>2519</lpage><pub-id pub-id-type="pmid">10644707</pub-id></mixed-citation>
</ref>
<ref id="b25-ad-9-3-537">
<label>[25]</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Xiao</surname><given-names>L</given-names></name>, <name><surname>Bai</surname><given-names>Y</given-names></name>, <name><surname>Qu</surname><given-names>A</given-names></name>, <name><surname>Zheng</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway</article-title>. <source/>PLoS One, <volume>7</volume>: <fpage>e36562</fpage><pub-id pub-id-type="pmid">22590567</pub-id></mixed-citation>
</ref>
<ref id="b26-ad-9-3-537">
<label>[26]</label>
<mixed-citation publication-type="journal"><name><surname>Thompson</surname><given-names>BJ</given-names></name>, <name><surname>Sahai</surname><given-names>E</given-names></name> (<year>2015</year>). <article-title>MST kinases in development and disease</article-title>. <source/>J Cell Biol, <volume>210</volume>: <fpage>871</fpage>-<lpage>882</lpage><pub-id pub-id-type="pmid">26370497</pub-id></mixed-citation>
</ref>
<ref id="b27-ad-9-3-537">
<label>[27]</label>
<mixed-citation publication-type="journal"><name><surname>Zalvide</surname><given-names>J</given-names></name>, <name><surname>Fidalgo</surname><given-names>M</given-names></name>, <name><surname>Fraile</surname><given-names>M</given-names></name>, <name><surname>Guerrero</surname><given-names>A</given-names></name>, <name><surname>Iglesias</surname><given-names>C</given-names></name>, <name><surname>Floridia</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>The CCM3-GCKIII partnership</article-title>. <source/>Histol Histopathol, <volume>28</volume>: <fpage>1265</fpage>-<lpage>1272</lpage><pub-id pub-id-type="pmid">23744102</pub-id></mixed-citation>
</ref>
<ref id="b28-ad-9-3-537">
<label>[28]</label>
<mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>EH</given-names></name>, <name><surname>Nousiainen</surname><given-names>M</given-names></name>, <name><surname>Chalamalasetty</surname><given-names>RB</given-names></name>, <name><surname>Schafer</surname><given-names>A</given-names></name>, <name><surname>Nigg</surname><given-names>EA</given-names></name>, <name><surname>Sillje</surname><given-names>HH</given-names></name> (<year>2005</year>). <article-title>The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1</article-title>. <source/>Oncogene, <volume>24</volume>: <fpage>2076</fpage>-<lpage>2086</lpage><pub-id pub-id-type="pmid">15688006</pub-id></mixed-citation>
</ref>
<ref id="b29-ad-9-3-537">
<label>[29]</label>
<mixed-citation publication-type="journal"><name><surname>Praskova</surname><given-names>M</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Avruch</surname><given-names>J</given-names></name> (<year>2008</year>). <article-title>MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation</article-title>. <source/>Curr Biol, <volume>18</volume>: <fpage>311</fpage>-<lpage>321</lpage><pub-id pub-id-type="pmid">18328708</pub-id></mixed-citation>
</ref>
<ref id="b30-ad-9-3-537">
<label>[30]</label>
<mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Tumaneng</surname><given-names>K</given-names></name>, <name><surname>Wang</surname><given-names>CY</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2010</year>). <article-title>A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)</article-title>. <source/>Genes Dev, <volume>24</volume>: <fpage>72</fpage>-<lpage>85</lpage><pub-id pub-id-type="pmid">20048001</pub-id></mixed-citation>
</ref>
<ref id="b31-ad-9-3-537">
<label>[31]</label>
<mixed-citation publication-type="journal"><name><surname>Moroishi</surname><given-names>T</given-names></name>, <name><surname>Park</surname><given-names>HW</given-names></name>, <name><surname>Qin</surname><given-names>B</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Meng</surname><given-names>Z</given-names></name>, <name><surname>Plouffe</surname><given-names>SW</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis</article-title>. <source/>Genes Dev, <volume>29</volume>: <fpage>1271</fpage>-<lpage>1284</lpage><pub-id pub-id-type="pmid">26109050</pub-id></mixed-citation>
</ref>
<ref id="b32-ad-9-3-537">
<label>[32]</label>
<mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>W</given-names></name>, <name><surname>Guan</surname><given-names>KL</given-names></name> (<year>2012</year>). <article-title>The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway</article-title>. <source/>Semin Cell Dev Biol, <volume>23</volume>: <fpage>785</fpage>-<lpage>793</lpage><pub-id pub-id-type="pmid">22659496</pub-id></mixed-citation>
</ref>
<ref id="b33-ad-9-3-537">
<label>[33]</label>
<mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>H</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Ji</surname><given-names>S</given-names></name>, <name><surname>Wei</surname><given-names>L</given-names></name>, <name><surname>Fan</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense</article-title>. <source/>Cell Rep, <volume>3</volume>: <fpage>1663</fpage>-<lpage>1677</lpage><pub-id pub-id-type="pmid">23684612</pub-id></mixed-citation>
</ref>
<ref id="b34-ad-9-3-537">
<label>[34]</label>
<mixed-citation publication-type="journal"><name><surname>Fernandez</surname><given-names>BG</given-names></name>, <name><surname>Gaspar</surname><given-names>P</given-names></name>, <name><surname>Bras-Pereira</surname><given-names>C</given-names></name>, <name><surname>Jezowska</surname><given-names>B</given-names></name>, <name><surname>Rebelo</surname><given-names>SR</given-names></name>, <name><surname>Janody</surname><given-names>F</given-names></name> (<year>2011</year>). <article-title>Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila</article-title>. <source/>Development, <volume>138</volume>: <fpage>2337</fpage>-<lpage>2346</lpage><pub-id pub-id-type="pmid">21525075</pub-id></mixed-citation>
</ref>
<ref id="b35-ad-9-3-537">
<label>[35]</label>
<mixed-citation publication-type="journal"><name><surname>Lucas</surname><given-names>EP</given-names></name>, <name><surname>Khanal</surname><given-names>I</given-names></name>, <name><surname>Gaspar</surname><given-names>P</given-names></name>, <name><surname>Fletcher</surname><given-names>GC</given-names></name>, <name><surname>Polesello</surname><given-names>C</given-names></name>, <name><surname>Tapon</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>The Hippo pathway polarizes the actin cytoskeleton during collective migration of Drosophila border cells</article-title>. <source/>J Cell Biol, <volume>201</volume>: <fpage>875</fpage>-<lpage>885</lpage><pub-id pub-id-type="pmid">23733343</pub-id></mixed-citation>
</ref>
<ref id="b36-ad-9-3-537">
<label>[36]</label>
<mixed-citation publication-type="journal"><name><surname>Lehtinen</surname><given-names>MK</given-names></name>, <name><surname>Yuan</surname><given-names>Z</given-names></name>, <name><surname>Boag</surname><given-names>PR</given-names></name>, <name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Villen</surname><given-names>J</given-names></name>, <name><surname>Becker</surname><given-names>EB</given-names></name>, <etal>et al</etal> (<year>2006</year>). <article-title>A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span</article-title>. <source/>Cell, <volume>125</volume>: <fpage>987</fpage>-<lpage>1001</lpage><pub-id pub-id-type="pmid">16751106</pub-id></mixed-citation>
</ref>
<ref id="b37-ad-9-3-537">
<label>[37]</label>
<mixed-citation publication-type="journal"><name><surname>Valis</surname><given-names>K</given-names></name>, <name><surname>Prochazka</surname><given-names>L</given-names></name>, <name><surname>Boura</surname><given-names>E</given-names></name>, <name><surname>Chladova</surname><given-names>J</given-names></name>, <name><surname>Obsil</surname><given-names>T</given-names></name>, <name><surname>Rohlena</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner</article-title>. <source/>Cancer Res, <volume>71</volume>: <fpage>946</fpage>-<lpage>954</lpage><pub-id pub-id-type="pmid">21245099</pub-id></mixed-citation>
</ref>
<ref id="b38-ad-9-3-537">
<label>[38]</label>
<mixed-citation publication-type="journal"><name><surname>Chung</surname><given-names>C</given-names></name>, <name><surname>Kim</surname><given-names>T</given-names></name>, <name><surname>Kim</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>M</given-names></name>, <name><surname>Song</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>TS</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>110</volume>: <fpage>7732</fpage>-<lpage>7737</lpage><pub-id pub-id-type="pmid">23620511</pub-id></mixed-citation>
</ref>
<ref id="b39-ad-9-3-537">
<label>[39]</label>
<mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>J</given-names></name>, <name><surname>Oh</surname><given-names>S</given-names></name>, <name><surname>Lee</surname><given-names>D</given-names></name>, <name><surname>Oh</surname><given-names>HJ</given-names></name>, <name><surname>Park</surname><given-names>JY</given-names></name>, <name><surname>Lee</surname><given-names>SB</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Mst1-FoxO signaling protects Naive T lymphocytes from cellular oxidative stress in mice</article-title>. <source/>PLoS One, <volume>4</volume>: <fpage>e8011</fpage><pub-id pub-id-type="pmid">19956688</pub-id></mixed-citation>
</ref>
<ref id="b40-ad-9-3-537">
<label>[40]</label>
<mixed-citation publication-type="journal"><name><surname>Ura</surname><given-names>S</given-names></name>, <name><surname>Nishina</surname><given-names>H</given-names></name>, <name><surname>Gotoh</surname><given-names>Y</given-names></name>, <name><surname>Katada</surname><given-names>T</given-names></name> (<year>2007</year>). <article-title>Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis</article-title>. <source/>Mol Cell Biol, <volume>27</volume>: <fpage>5514</fpage>-<lpage>5522</lpage><pub-id pub-id-type="pmid">17548476</pub-id></mixed-citation>
</ref>
<ref id="b41-ad-9-3-537">
<label>[41]</label>
<mixed-citation publication-type="journal"><name><surname>Densham</surname><given-names>RM</given-names></name>, <name><surname>OâNeill</surname><given-names>E</given-names></name>, <name><surname>Munro</surname><given-names>J</given-names></name>, <name><surname>Konig</surname><given-names>I</given-names></name>, <name><surname>Anderson</surname><given-names>K</given-names></name>, <name><surname>Kolch</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability</article-title>. <source/>Mol Cell Biol, <volume>29</volume>: <fpage>6380</fpage>-<lpage>6390</lpage><pub-id pub-id-type="pmid">19822666</pub-id></mixed-citation>
</ref>
<ref id="b42-ad-9-3-537">
<label>[42]</label>
<mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>TJ</given-names></name>, <name><surname>Lai</surname><given-names>WY</given-names></name>, <name><surname>Huang</surname><given-names>CY</given-names></name>, <name><surname>Hsieh</surname><given-names>WJ</given-names></name>, <name><surname>Yu</surname><given-names>JS</given-names></name>, <name><surname>Hsieh</surname><given-names>YJ</given-names></name>, <etal>et al</etal> (<year>2006</year>). <article-title>Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST</article-title>. <source/>J Biol Chem, <volume>281</volume>: <fpage>38405</fpage>-<lpage>38417</lpage><pub-id pub-id-type="pmid">17046825</pub-id></mixed-citation>
</ref>
<ref id="b43-ad-9-3-537">
<label>[43]</label>
<mixed-citation publication-type="journal"><name><surname>ten Klooster</surname><given-names>JP</given-names></name>, <name><surname>Jansen</surname><given-names>M</given-names></name>, <name><surname>Yuan</surname><given-names>J</given-names></name>, <name><surname>Oorschot</surname><given-names>V</given-names></name>, <name><surname>Begthel</surname><given-names>H</given-names></name>, <name><surname>Di Giacomo</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>Mst4 and Ezrin induce brush borders downstream of the Lkb1/Strad/Mo25 polarization complex</article-title>. <source/>Dev Cell, <volume>16</volume>: <fpage>551</fpage>-<lpage>562</lpage><pub-id pub-id-type="pmid">19386264</pub-id></mixed-citation>
</ref>
<ref id="b44-ad-9-3-537">
<label>[44]</label>
<mixed-citation publication-type="journal"><name><surname>Fuller</surname><given-names>SJ</given-names></name>, <name><surname>McGuffin</surname><given-names>LJ</given-names></name>, <name><surname>Marshall</surname><given-names>AK</given-names></name>, <name><surname>Giraldo</surname><given-names>A</given-names></name>, <name><surname>Pikkarainen</surname><given-names>S</given-names></name>, <name><surname>Clerk</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3)</article-title>. <source/>Biochem J, <volume>442</volume>: <fpage>595</fpage>-<lpage>610</lpage><pub-id pub-id-type="pmid">22229648</pub-id></mixed-citation>
</ref>
<ref id="b45-ad-9-3-537">
<label>[45]</label>
<mixed-citation publication-type="journal"><name><surname>Madsen</surname><given-names>CD</given-names></name>, <name><surname>Hooper</surname><given-names>S</given-names></name>, <name><surname>Tozluoglu</surname><given-names>M</given-names></name>, <name><surname>Bruckbauer</surname><given-names>A</given-names></name>, <name><surname>Fletcher</surname><given-names>G</given-names></name>, <name><surname>Erler</surname><given-names>JT</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>STRIPAK components determine mode of cancer cell migration and metastasis</article-title>. <source/>Nat Cell Biol, <volume>17</volume>: <fpage>68</fpage>-<lpage>80</lpage><pub-id pub-id-type="pmid">25531779</pub-id></mixed-citation>
</ref>
<ref id="b46-ad-9-3-537">
<label>[46]</label>
<mixed-citation publication-type="journal"><name><surname>Halle</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>YC</given-names></name>, <name><surname>Hardy</surname><given-names>S</given-names></name>, <name><surname>Theberge</surname><given-names>JF</given-names></name>, <name><surname>Blanchetot</surname><given-names>C</given-names></name>, <name><surname>Bourdeau</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response</article-title>. <source/>Mol Cell Biol, <volume>27</volume>: <fpage>1172</fpage>-<lpage>1190</lpage><pub-id pub-id-type="pmid">17130234</pub-id></mixed-citation>
</ref>
<ref id="b47-ad-9-3-537">
<label>[47]</label>
<mixed-citation publication-type="journal"><name><surname>Stegert</surname><given-names>MR</given-names></name>, <name><surname>Hergovich</surname><given-names>A</given-names></name>, <name><surname>Tamaskovic</surname><given-names>R</given-names></name>, <name><surname>Bichsel</surname><given-names>SJ</given-names></name>, <name><surname>Hemmings</surname><given-names>BA</given-names></name> (<year>2005</year>). <article-title>Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3</article-title>. <source/>Mol Cell Biol, <volume>25</volume>: <fpage>11019</fpage>-<lpage>11029</lpage><pub-id pub-id-type="pmid">16314523</pub-id></mixed-citation>
</ref>
<ref id="b48-ad-9-3-537">
<label>[48]</label>
<mixed-citation publication-type="journal"><name><surname>Ultanir</surname><given-names>SK</given-names></name>, <name><surname>Yadav</surname><given-names>S</given-names></name>, <name><surname>Hertz</surname><given-names>NT</given-names></name>, <name><surname>Oses-Prieto</surname><given-names>JA</given-names></name>, <name><surname>Claxton</surname><given-names>S</given-names></name>, <name><surname>Burlingame</surname><given-names>AL</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development</article-title>. <source/>Neuron, <volume>84</volume>: <fpage>968</fpage>-<lpage>982</lpage><pub-id pub-id-type="pmid">25456499</pub-id></mixed-citation>
</ref>
<ref id="b49-ad-9-3-537">
<label>[49]</label>
<mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Wang</surname><given-names>LH</given-names></name>, <name><surname>Liu</surname><given-names>CY</given-names></name>, <name><surname>Lei</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein</article-title>. <source/>Genes Dev, <volume>25</volume>: <fpage>51</fpage>-<lpage>63</lpage><pub-id pub-id-type="pmid">21205866</pub-id></mixed-citation>
</ref>
<ref id="b50-ad-9-3-537">
<label>[50]</label>
<mixed-citation publication-type="journal"><name><surname>Dupont</surname><given-names>S</given-names></name>, <name><surname>Morsut</surname><given-names>L</given-names></name>, <name><surname>Aragona</surname><given-names>M</given-names></name>, <name><surname>Enzo</surname><given-names>E</given-names></name>, <name><surname>Giulitti</surname><given-names>S</given-names></name>, <name><surname>Cordenonsi</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Role of YAP/TAZ in mechanotransduction</article-title>. <source/>Nature, <volume>474</volume>: <fpage>179</fpage>-<lpage>183</lpage><pub-id pub-id-type="pmid">21654799</pub-id></mixed-citation>
</ref>
<ref id="b51-ad-9-3-537">
<label>[51]</label>
<mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>FX</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Panupinthu</surname><given-names>N</given-names></name>, <name><surname>Jewell</surname><given-names>JL</given-names></name>, <name><surname>Lian</surname><given-names>I</given-names></name>, <name><surname>Wang</surname><given-names>LH</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling</article-title>. <source/>Cell, <volume>150</volume>: <fpage>780</fpage>-<lpage>791</lpage><pub-id pub-id-type="pmid">22863277</pub-id></mixed-citation>
</ref>
<ref id="b52-ad-9-3-537">
<label>[52]</label>
<mixed-citation publication-type="journal"><name><surname>Avruch</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>D</given-names></name>, <name><surname>Fitamant</surname><given-names>J</given-names></name>, <name><surname>Bardeesy</surname><given-names>N</given-names></name>, <name><surname>Mou</surname><given-names>F</given-names></name>, <name><surname>Barrufet</surname><given-names>LR</given-names></name> (<year>2012</year>). <article-title>Protein kinases of the Hippo pathway: regulation and substrates</article-title>. <source/>Semin Cell Dev Biol, <volume>23</volume>: <fpage>770</fpage>-<lpage>784</lpage><pub-id pub-id-type="pmid">22898666</pub-id></mixed-citation>
</ref>
<ref id="b53-ad-9-3-537">
<label>[53]</label>
<mixed-citation publication-type="journal"><name><surname>Scheel</surname><given-names>H</given-names></name>, <name><surname>Hofmann</surname><given-names>K</given-names></name> (<year>2003</year>). <article-title>A novel interaction motif, SARAH, connects three classes of tumor suppressor</article-title>. <source/>Curr Biol, <volume>13</volume>: <fpage>R899</fpage>-<lpage>900</lpage><pub-id pub-id-type="pmid">14654011</pub-id></mixed-citation>
</ref>
<ref id="b54-ad-9-3-537">
<label>[54]</label>
<mixed-citation publication-type="journal"><name><surname>Tapon</surname><given-names>N</given-names></name>, <name><surname>Harvey</surname><given-names>KF</given-names></name>, <name><surname>Bell</surname><given-names>DW</given-names></name>, <name><surname>Wahrer</surname><given-names>DC</given-names></name>, <name><surname>Schiripo</surname><given-names>TA</given-names></name>, <name><surname>Haber</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2002</year>). <article-title>salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines</article-title>. <source/>Cell, <volume>110</volume>: <fpage>467</fpage>-<lpage>478</lpage><pub-id pub-id-type="pmid">12202036</pub-id></mixed-citation>
</ref>
<ref id="b55-ad-9-3-537">
<label>[55]</label>
<mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>H</given-names></name>, <name><surname>Oh</surname><given-names>S</given-names></name>, <name><surname>Oh</surname><given-names>HJ</given-names></name>, <name><surname>Lim</surname><given-names>DS</given-names></name> (<year>2010</year>). <article-title>Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity</article-title>. <source/>Biochem Biophys Res Commun, <volume>391</volume>: <fpage>969</fpage>-<lpage>973</lpage><pub-id pub-id-type="pmid">19962960</pub-id></mixed-citation>
</ref>
<ref id="b56-ad-9-3-537">
<label>[56]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>KK</given-names></name>, <name><surname>Murakawa</surname><given-names>M</given-names></name>, <name><surname>Nishida</surname><given-names>E</given-names></name>, <name><surname>Tsubuki</surname><given-names>S</given-names></name>, <name><surname>Kawashima</surname><given-names>S</given-names></name>, <name><surname>Sakamaki</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>1998</year>). <article-title>Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosis</article-title>. <source/>Oncogene, <volume>16</volume>: <fpage>3029</fpage>-<lpage>3037</lpage><pub-id pub-id-type="pmid">9662336</pub-id></mixed-citation>
</ref>
<ref id="b57-ad-9-3-537">
<label>[57]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>KK</given-names></name>, <name><surname>Ohyama</surname><given-names>T</given-names></name>, <name><surname>Yajima</surname><given-names>N</given-names></name>, <name><surname>Tsubuki</surname><given-names>S</given-names></name>, <name><surname>Yonehara</surname><given-names>S</given-names></name> (<year>2001</year>). <article-title>MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation</article-title>. <source/>J Biol Chem, <volume>276</volume>: <fpage>19276</fpage>-<lpage>19285</lpage><pub-id pub-id-type="pmid">11278283</pub-id></mixed-citation>
</ref>
<ref id="b58-ad-9-3-537">
<label>[58]</label>
<mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>JJ</given-names></name>, <name><surname>Lee</surname><given-names>YJ</given-names></name> (<year>2008</year>). <article-title>Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily</article-title>. <source/>Cell Signal, <volume>20</volume>: <fpage>892</fpage>-<lpage>906</lpage><pub-id pub-id-type="pmid">18276109</pub-id></mixed-citation>
</ref>
<ref id="b59-ad-9-3-537">
<label>[59]</label>
<mixed-citation publication-type="journal"><name><surname>Ribeiro</surname><given-names>PS</given-names></name>, <name><surname>Josue</surname><given-names>F</given-names></name>, <name><surname>Wepf</surname><given-names>A</given-names></name>, <name><surname>Wehr</surname><given-names>MC</given-names></name>, <name><surname>Rinner</surname><given-names>O</given-names></name>, <name><surname>Kelly</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of Hippo signaling</article-title>. <source/>Mol Cell, <volume>39</volume>: <fpage>521</fpage>-<lpage>534</lpage><pub-id pub-id-type="pmid">20797625</pub-id></mixed-citation>
</ref>
<ref id="b60-ad-9-3-537">
<label>[60]</label>
<mixed-citation publication-type="journal"><name><surname>Poon</surname><given-names>CL</given-names></name>, <name><surname>Lin</surname><given-names>JI</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Harvey</surname><given-names>KF</given-names></name> (<year>2011</year>). <article-title>The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway</article-title>. <source/>Dev Cell, <volume>21</volume>: <fpage>896</fpage>-<lpage>906</lpage><pub-id pub-id-type="pmid">22075148</pub-id></mixed-citation>
</ref>
<ref id="b61-ad-9-3-537">
<label>[61]</label>
<mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>CY</given-names></name>, <name><surname>Wu</surname><given-names>YM</given-names></name>, <name><surname>Hsu</surname><given-names>CY</given-names></name>, <name><surname>Lee</surname><given-names>WS</given-names></name>, <name><surname>Lai</surname><given-names>MD</given-names></name>, <name><surname>Lu</surname><given-names>TJ</given-names></name>, <etal>et al</etal> (<year>2002</year>). <article-title>Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis</article-title>. <source/>J Biol Chem, <volume>277</volume>: <fpage>34367</fpage>-<lpage>34374</lpage><pub-id pub-id-type="pmid">12107159</pub-id></mixed-citation>
</ref>
<ref id="b62-ad-9-3-537">
<label>[62]</label>
<mixed-citation publication-type="journal"><name><surname>Dong</surname><given-names>Y</given-names></name>, <name><surname>Du</surname><given-names>X</given-names></name>, <name><surname>Ye</surname><given-names>J</given-names></name>, <name><surname>Han</surname><given-names>M</given-names></name>, <name><surname>Xu</surname><given-names>T</given-names></name>, <name><surname>Zhuang</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>A cell-intrinsic role for Mst1 in regulating thymocyte egress</article-title>. <source/>J Immunol, <volume>183</volume>: <fpage>3865</fpage>-<lpage>3872</lpage><pub-id pub-id-type="pmid">19692642</pub-id></mixed-citation>
</ref>
<ref id="b63-ad-9-3-537">
<label>[63]</label>
<mixed-citation publication-type="journal"><name><surname>Mou</surname><given-names>F</given-names></name>, <name><surname>Praskova</surname><given-names>M</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Van Buren</surname><given-names>D</given-names></name>, <name><surname>Hock</surname><given-names>H</given-names></name>, <name><surname>Avruch</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes</article-title>. <source/>J Exp Med, <volume>209</volume>: <fpage>741</fpage>-<lpage>759</lpage><pub-id pub-id-type="pmid">22412158</pub-id></mixed-citation>
</ref>
<ref id="b64-ad-9-3-537">
<label>[64]</label>
<mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>SM</given-names></name>, <name><surname>Bossuyt</surname><given-names>W</given-names></name>, <name><surname>Liu</surname><given-names>P</given-names></name>, <name><surname>Qiu</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>107</volume>: <fpage>1437</fpage>-<lpage>1442</lpage><pub-id pub-id-type="pmid">20080689</pub-id></mixed-citation>
</ref>
<ref id="b65-ad-9-3-537">
<label>[65]</label>
<mixed-citation publication-type="journal"><name><surname>Yamamoto</surname><given-names>S</given-names></name>, <name><surname>Yang</surname><given-names>G</given-names></name>, <name><surname>Zablocki</surname><given-names>D</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Hong</surname><given-names>C</given-names></name>, <name><surname>Kim</surname><given-names>SJ</given-names></name>, <etal>et al</etal> (<year>2003</year>). <article-title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</article-title>. <source/>J Clin Invest, <volume>111</volume>: <fpage>1463</fpage>-<lpage>1474</lpage><pub-id pub-id-type="pmid">12750396</pub-id></mixed-citation>
</ref>
<ref id="b66-ad-9-3-537">
<label>[66]</label>
<mixed-citation publication-type="journal"><name><surname>von Gise</surname><given-names>A</given-names></name>, <name><surname>Lin</surname><given-names>Z</given-names></name>, <name><surname>Schlegelmilch</surname><given-names>K</given-names></name>, <name><surname>Honor</surname><given-names>LB</given-names></name>, <name><surname>Pan</surname><given-names>GM</given-names></name>, <name><surname>Buck</surname><given-names>JN</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>109</volume>: <fpage>2394</fpage>-<lpage>2399</lpage><pub-id pub-id-type="pmid">22308401</pub-id></mixed-citation>
</ref>
<ref id="b67-ad-9-3-537">
<label>[67]</label>
<mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>D</given-names></name>, <name><surname>Hu</surname><given-names>P</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death</article-title>. <source/>J Neurosci, <volume>31</volume>: <fpage>9611</fpage>-<lpage>9619</lpage><pub-id pub-id-type="pmid">21715626</pub-id></mixed-citation>
</ref>
<ref id="b68-ad-9-3-537">
<label>[68]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Seo</surname><given-names>BR</given-names></name>, <name><surname>Choi</surname><given-names>EJ</given-names></name>, <name><surname>Koh</surname><given-names>JY</given-names></name> (<year>2014</year>). <article-title>The role of reciprocal activation of cAbl and Mst1 in the oxidative death of cultured astrocytes</article-title>. <source/>Glia, <volume>62</volume>: <fpage>639</fpage>-<lpage>648</lpage><pub-id pub-id-type="pmid">24464935</pub-id></mixed-citation>
</ref>
<ref id="b69-ad-9-3-537">
<label>[69]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SJ</given-names></name>, <name><surname>Cho</surname><given-names>KS</given-names></name>, <name><surname>Kim</surname><given-names>HN</given-names></name>, <name><surname>Kim</surname><given-names>HJ</given-names></name>, <name><surname>Koh</surname><given-names>JY</given-names></name> (<year>2011</year>). <article-title>Role of zinc metallothionein-3 (ZnMt3) in epidermal growth factor (EGF)-induced c-Abl protein activation and actin polymerization in cultured astrocytes</article-title>. <source/>J Biol Chem, <volume>286</volume>: <fpage>40847</fpage>-<lpage>40856</lpage><pub-id pub-id-type="pmid">21900236</pub-id></mixed-citation>
</ref>
<ref id="b70-ad-9-3-537">
<label>[70]</label>
<mixed-citation publication-type="journal"><name><surname>Yun</surname><given-names>HJ</given-names></name>, <name><surname>Yoon</surname><given-names>JH</given-names></name>, <name><surname>Lee</surname><given-names>JK</given-names></name>, <name><surname>Noh</surname><given-names>KT</given-names></name>, <name><surname>Yoon</surname><given-names>KW</given-names></name>, <name><surname>Oh</surname><given-names>SP</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling</article-title>. <source/>EMBO J, <volume>30</volume>: <fpage>2465</fpage>-<lpage>2476</lpage><pub-id pub-id-type="pmid">21572393</pub-id></mixed-citation>
</ref>
<ref id="b71-ad-9-3-537">
<label>[71]</label>
<mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>J</given-names></name>, <name><surname>Ip</surname><given-names>JP</given-names></name>, <name><surname>Ye</surname><given-names>T</given-names></name>, <name><surname>Ng</surname><given-names>YP</given-names></name>, <name><surname>Yung</surname><given-names>WH</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Cdk5-dependent Mst3 phosphorylation and activity regulate neuronal migration through RhoA inhibition</article-title>. <source/>J Neurosci, <volume>34</volume>: <fpage>7425</fpage>-<lpage>7436</lpage><pub-id pub-id-type="pmid">24872548</pub-id></mixed-citation>
</ref>
<ref id="b72-ad-9-3-537">
<label>[72]</label>
<mixed-citation publication-type="journal"><name><surname>Irwin</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>YM</given-names></name>, <name><surname>OâToole</surname><given-names>JE</given-names></name>, <name><surname>Benowitz</surname><given-names>LI</given-names></name> (<year>2006</year>). <article-title>Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>103</volume>: <fpage>18320</fpage>-<lpage>18325</lpage><pub-id pub-id-type="pmid">17114295</pub-id></mixed-citation>
</ref>
<ref id="b73-ad-9-3-537">
<label>[73]</label>
<mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Yu</surname><given-names>L</given-names></name>, <name><surname>Gunel</surname><given-names>M</given-names></name>, <name><surname>Boggon</surname><given-names>TJ</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development</article-title>. <source/>Sci Signal, <volume>3</volume>: <fpage>ra26</fpage><pub-id pub-id-type="pmid">20371769</pub-id></mixed-citation>
</ref>
<ref id="b74-ad-9-3-537">
<label>[74]</label>
<mixed-citation publication-type="journal"><name><surname>Fidalgo</surname><given-names>M</given-names></name>, <name><surname>Guerrero</surname><given-names>A</given-names></name>, <name><surname>Fraile</surname><given-names>M</given-names></name>, <name><surname>Iglesias</surname><given-names>C</given-names></name>, <name><surname>Pombo</surname><given-names>CM</given-names></name>, <name><surname>Zalvide</surname><given-names>J</given-names></name> (<year>2012</year>). <article-title>Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress</article-title>. <source/>J Biol Chem, <volume>287</volume>: <fpage>11556</fpage>-<lpage>11565</lpage><pub-id pub-id-type="pmid">22291017</pub-id></mixed-citation>
</ref>
<ref id="b75-ad-9-3-537">
<label>[75]</label>
<mixed-citation publication-type="journal"><name><surname>Ma</surname><given-names>X</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>, <name><surname>Shan</surname><given-names>J</given-names></name>, <name><surname>Long</surname><given-names>F</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway</article-title>. <source/>Mol Biol Cell, <volume>18</volume>: <fpage>1965</fpage>-<lpage>1978</lpage><pub-id pub-id-type="pmid">17360971</pub-id></mixed-citation>
</ref>
<ref id="b76-ad-9-3-537">
<label>[76]</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Ma</surname><given-names>X</given-names></name>, <name><surname>Deng</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Mo</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>PDCD10 interacts with STK25 to accelerate cell apoptosis under oxidative stress</article-title>. <source/>Front Biosci (Landmark Ed), <volume>17</volume>: <fpage>2295</fpage>-<lpage>2305</lpage><pub-id pub-id-type="pmid">22652780</pub-id></mixed-citation>
</ref>
<ref id="b77-ad-9-3-537">
<label>[77]</label>
<mixed-citation publication-type="journal"><name><surname>Matsuki</surname><given-names>T</given-names></name>, <name><surname>Matthews</surname><given-names>RT</given-names></name>, <name><surname>Cooper</surname><given-names>JA</given-names></name>, <name><surname>van der Brug</surname><given-names>MP</given-names></name>, <name><surname>Cookson</surname><given-names>MR</given-names></name>, <name><surname>Hardy</surname><given-names>JA</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment</article-title>. <source/>Cell, <volume>143</volume>: <fpage>826</fpage>-<lpage>836</lpage><pub-id pub-id-type="pmid">21111240</pub-id></mixed-citation>
</ref>
<ref id="b78-ad-9-3-537">
<label>[78]</label>
<mixed-citation publication-type="journal"><name><surname>Rice</surname><given-names>DS</given-names></name>, <name><surname>Curran</surname><given-names>T</given-names></name> (<year>2001</year>). <article-title>Role of the reelin signaling pathway in central nervous system development</article-title>. <source/>Annu Rev Neurosci, <volume>24</volume>: <fpage>1005</fpage>-<lpage>1039</lpage><pub-id pub-id-type="pmid">11520926</pub-id></mixed-citation>
</ref>
<ref id="b79-ad-9-3-537">
<label>[79]</label>
<mixed-citation publication-type="journal"><name><surname>Matsuki</surname><given-names>T</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Howell</surname><given-names>BW</given-names></name> (<year>2013</year>). <article-title>Acute inactivation of the serine-threonine kinase Stk25 disrupts neuronal migration</article-title>. <source/>Neural Dev, <volume>8</volume>: <fpage>21</fpage><pub-id pub-id-type="pmid">24225308</pub-id></mixed-citation>
</ref>
<ref id="b80-ad-9-3-537">
<label>[80]</label>
<mixed-citation publication-type="journal"><name><surname>Minoo</surname><given-names>P</given-names></name>, <name><surname>Zlobec</surname><given-names>I</given-names></name>, <name><surname>Baker</surname><given-names>K</given-names></name>, <name><surname>Tornillo</surname><given-names>L</given-names></name>, <name><surname>Terracciano</surname><given-names>L</given-names></name>, <name><surname>Jass</surname><given-names>JR</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer</article-title>. <source/>Mod Pathol, <volume>20</volume>: <fpage>331</fpage>-<lpage>338</lpage><pub-id pub-id-type="pmid">17277767</pub-id></mixed-citation>
</ref>
<ref id="b81-ad-9-3-537">
<label>[81]</label>
<mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>TS</given-names></name>, <name><surname>Lee</surname><given-names>DH</given-names></name>, <name><surname>Kim</surname><given-names>SK</given-names></name>, <name><surname>Shin</surname><given-names>SY</given-names></name>, <name><surname>Seo</surname><given-names>EJ</given-names></name>, <name><surname>Lim</surname><given-names>DS</given-names></name> (<year>2012</year>). <article-title>Mammalian sterile 20-like kinase 1 suppresses lymphoma development by promoting faithful chromosome segregation</article-title>. <source/>Cancer Res, <volume>72</volume>: <fpage>5386</fpage>-<lpage>5395</lpage><pub-id pub-id-type="pmid">22926556</pub-id></mixed-citation>
</ref>
<ref id="b82-ad-9-3-537">
<label>[82]</label>
<mixed-citation publication-type="journal"><name><surname>Fernandez</surname><given-names>LA</given-names></name>, <name><surname>Northcott</surname><given-names>PA</given-names></name>, <name><surname>Dalton</surname><given-names>J</given-names></name>, <name><surname>Fraga</surname><given-names>C</given-names></name>, <name><surname>Ellison</surname><given-names>D</given-names></name>, <name><surname>Angers</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation</article-title>. <source/>Genes Dev, <volume>23</volume>: <fpage>2729</fpage>-<lpage>2741</lpage><pub-id pub-id-type="pmid">19952108</pub-id></mixed-citation>
</ref>
<ref id="b83-ad-9-3-537">
<label>[83]</label>
<mixed-citation publication-type="journal"><name><surname>Murakami</surname><given-names>H</given-names></name>, <name><surname>Mizuno</surname><given-names>T</given-names></name>, <name><surname>Taniguchi</surname><given-names>T</given-names></name>, <name><surname>Fujii</surname><given-names>M</given-names></name>, <name><surname>Ishiguro</surname><given-names>F</given-names></name>, <name><surname>Fukui</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2011</year>). <article-title>LATS2 is a tumor suppressor gene of malignant mesothelioma</article-title>. <source/>Cancer Res, <volume>71</volume>: <fpage>873</fpage>-<lpage>883</lpage><pub-id pub-id-type="pmid">21245096</pub-id></mixed-citation>
</ref>
<ref id="b84-ad-9-3-537">
<label>[84]</label>
<mixed-citation publication-type="journal"><name><surname>Lau</surname><given-names>AN</given-names></name>, <name><surname>Curtis</surname><given-names>SJ</given-names></name>, <name><surname>Fillmore</surname><given-names>CM</given-names></name>, <name><surname>Rowbotham</surname><given-names>SP</given-names></name>, <name><surname>Mohseni</surname><given-names>M</given-names></name>, <name><surname>Wagner</surname><given-names>DE</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis</article-title>. <source/>EMBO J, <volume>33</volume>: <fpage>468</fpage>-<lpage>481</lpage><pub-id pub-id-type="pmid">24497554</pub-id></mixed-citation>
</ref>
<ref id="b85-ad-9-3-537">
<label>[85]</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Cooper</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>, <name><surname>Zagzag</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus</article-title>. <source/>Cancer Cell, <volume>26</volume>: <fpage>48</fpage>-<lpage>60</lpage><pub-id pub-id-type="pmid">25026211</pub-id></mixed-citation>
</ref>
<ref id="b86-ad-9-3-537">
<label>[86]</label>
<mixed-citation publication-type="journal"><name><surname>Camargo</surname><given-names>FD</given-names></name>, <name><surname>Gokhale</surname><given-names>S</given-names></name>, <name><surname>Johnnidis</surname><given-names>JB</given-names></name>, <name><surname>Fu</surname><given-names>D</given-names></name>, <name><surname>Bell</surname><given-names>GW</given-names></name>, <name><surname>Jaenisch</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>YAP1 increases organ size and expands undifferentiated progenitor cells</article-title>. <source/>Curr Biol, <volume>17</volume>: <fpage>2054</fpage>-<lpage>2060</lpage><pub-id pub-id-type="pmid">17980593</pub-id></mixed-citation>
</ref>
<ref id="b87-ad-9-3-537">
<label>[87]</label>
<mixed-citation publication-type="journal"><name><surname>Schulz</surname><given-names>A</given-names></name>, <name><surname>Zoch</surname><given-names>A</given-names></name>, <name><surname>Morrison</surname><given-names>H</given-names></name> (<year>2014</year>). <article-title>A neuronal function of the tumor suppressor protein merlin</article-title>. <source/>Acta Neuropathol Commun, <volume>2</volume>: <fpage>82</fpage><pub-id pub-id-type="pmid">25012216</pub-id></mixed-citation>
</ref>
<ref id="b88-ad-9-3-537">
<label>[88]</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Geng</surname><given-names>D</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <name><surname>Qi</surname><given-names>Y</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>Expression and significance of Hippo/YAP signaling in glioma progression</article-title>. <source/>Tumour Biol</mixed-citation>
</ref>
<ref id="b89-ad-9-3-537">
<label>[89]</label>
<mixed-citation publication-type="journal"><name><surname>Bartel</surname><given-names>DP</given-names></name> (<year>2004</year>). <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title>. <source/>Cell, <volume>116</volume>: <fpage>281</fpage>-<lpage>297</lpage><pub-id pub-id-type="pmid">14744438</pub-id></mixed-citation>
</ref>
<ref id="b90-ad-9-3-537">
<label>[90]</label>
<mixed-citation publication-type="journal"><name><surname>Ambros</surname><given-names>V</given-names></name> (<year>2004</year>). <article-title>The functions of animal microRNAs</article-title>. <source/>Nature, <volume>431</volume>: <fpage>350</fpage>-<lpage>355</lpage><pub-id pub-id-type="pmid">15372042</pub-id></mixed-citation>
</ref>
<ref id="b91-ad-9-3-537">
<label>[91]</label>
<mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Mijiti</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Wu</surname><given-names>PF</given-names></name>, <name><surname>Jiafu</surname><given-names>D</given-names></name> (<year>2015</year>). <article-title>Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway</article-title>. <source/>Biochem Biophys Res Commun, <volume>465</volume>: <fpage>194</fpage>-<lpage>199</lpage><pub-id pub-id-type="pmid">26241672</pub-id></mixed-citation>
</ref>
<ref id="b92-ad-9-3-537">
<label>[92]</label>
<mixed-citation publication-type="journal"><name><surname>Cassinelli</surname><given-names>G</given-names></name>, <name><surname>Zuco</surname><given-names>V</given-names></name>, <name><surname>Gatti</surname><given-names>L</given-names></name>, <name><surname>Lanzi</surname><given-names>C</given-names></name>, <name><surname>Zaffaroni</surname><given-names>N</given-names></name>, <name><surname>Colombo</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells</article-title>. <source/>Curr Med Chem, <volume>20</volume>: <fpage>1923</fpage>-<lpage>1945</lpage><pub-id pub-id-type="pmid">23410153</pub-id></mixed-citation>
</ref>
<ref id="b93-ad-9-3-537">
<label>[93]</label>
<mixed-citation publication-type="journal"><name><surname>Amornphimoltham</surname><given-names>P</given-names></name>, <name><surname>Sriuranpong</surname><given-names>V</given-names></name>, <name><surname>Patel</surname><given-names>V</given-names></name>, <name><surname>Benavides</surname><given-names>F</given-names></name>, <name><surname>Conti</surname><given-names>CJ</given-names></name>, <name><surname>Sauk</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2004</year>). <article-title>Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01</article-title>. <source/>Clin Cancer Res, <volume>10</volume>: <fpage>4029</fpage>-<lpage>4037</lpage><pub-id pub-id-type="pmid">15217935</pub-id></mixed-citation>
</ref>
<ref id="b94-ad-9-3-537">
<label>[94]</label>
<mixed-citation publication-type="journal"><name><surname>Qi</surname><given-names>Z</given-names></name>, <name><surname>Yan</surname><given-names>F</given-names></name>, <name><surname>Shi</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Dong</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats</article-title>. <source/>Transl Stroke Res, <volume>5</volume>: <fpage>501</fpage>-<lpage>509</lpage><pub-id pub-id-type="pmid">24804941</pub-id></mixed-citation>
</ref>
<ref id="b95-ad-9-3-537">
<label>[95]</label>
<mixed-citation publication-type="journal"><name><surname>Akhavan</surname><given-names>D</given-names></name>, <name><surname>Cloughesy</surname><given-names>TF</given-names></name>, <name><surname>Mischel</surname><given-names>PS</given-names></name> (<year>2010</year>). <article-title>mTOR signaling in glioblastoma: lessons learned from bench to bedside</article-title>. <source/>Neuro Oncol, <volume>12</volume>: <fpage>882</fpage>-<lpage>889</lpage><pub-id pub-id-type="pmid">20472883</pub-id></mixed-citation>
</ref>
<ref id="b96-ad-9-3-537">
<label>[96]</label>
<mixed-citation publication-type="journal"><name><surname>Sami</surname><given-names>A</given-names></name>, <name><surname>Karsy</surname><given-names>M</given-names></name> (<year>2013</year>). <article-title>Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding</article-title>. <source/>Tumour Biol, <volume>34</volume>: <fpage>1991</fpage>-<lpage>2002</lpage><pub-id pub-id-type="pmid">23625692</pub-id></mixed-citation>
</ref>
<ref id="b97-ad-9-3-537">
<label>[97]</label>
<mixed-citation publication-type="journal"><name><surname>Chao</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Ma</surname><given-names>P</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway</article-title>. <source/>J Neurooncol, <volume>121</volume>: <fpage>279</fpage>-<lpage>288</lpage><pub-id pub-id-type="pmid">25373346</pub-id></mixed-citation>
</ref>
<ref id="b98-ad-9-3-537">
<label>[98]</label>
<mixed-citation publication-type="journal"><name><surname>Tozluoglu</surname><given-names>M</given-names></name>, <name><surname>Mao</surname><given-names>Y</given-names></name>, <name><surname>Bates</surname><given-names>PA</given-names></name>, <name><surname>Sahai</surname><given-names>E</given-names></name> (<year>2015</year>). <article-title>Cost-benefit analysis of the mechanisms that enable migrating cells to sustain motility upon changes in matrix environments</article-title>. <source/>J R Soc Interface, <fpage>12</fpage></mixed-citation>
</ref>
<ref id="b99-ad-9-3-537">
<label>[99]</label>
<mixed-citation publication-type="journal"><name><surname>Costa</surname><given-names>B</given-names></name>, <name><surname>Kean</surname><given-names>MJ</given-names></name>, <name><surname>Ast</surname><given-names>V</given-names></name>, <name><surname>Knight</surname><given-names>JD</given-names></name>, <name><surname>Mett</surname><given-names>A</given-names></name>, <name><surname>Levy</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin</article-title>. <source/>J Biol Chem, <volume>287</volume>: <fpage>29285</fpage>-<lpage>29289</lpage><pub-id pub-id-type="pmid">22782892</pub-id></mixed-citation>
</ref>
<ref id="b100-ad-9-3-537">
<label>[100]</label>
<mixed-citation publication-type="journal"><name><surname>Harel</surname><given-names>L</given-names></name>, <name><surname>Costa</surname><given-names>B</given-names></name>, <name><surname>Tcherpakov</surname><given-names>M</given-names></name>, <name><surname>Zapatka</surname><given-names>M</given-names></name>, <name><surname>Oberthuer</surname><given-names>A</given-names></name>, <name><surname>Hansford</surname><given-names>LM</given-names></name>, <etal>et al</etal> (<year>2009</year>). <article-title>CCM2 mediates death signaling by the TrkA receptor tyrosine kinase</article-title>. <source/>Neuron, <volume>63</volume>: <fpage>585</fpage>-<lpage>591</lpage><pub-id pub-id-type="pmid">19755102</pub-id></mixed-citation>
</ref>
<ref id="b101-ad-9-3-537">
<label>[101]</label>
<mixed-citation publication-type="journal"><name><surname>Fisher</surname><given-names>M</given-names></name>, <name><surname>Vasilevko</surname><given-names>V</given-names></name>, <name><surname>Cribbs</surname><given-names>DH</given-names></name> (<year>2012</year>). <article-title>Mixed cerebrovascular disease and the future of stroke prevention</article-title>. <source/>Transl Stroke Res, <volume>3</volume>: <fpage>39</fpage>-<lpage>51</lpage><pub-id pub-id-type="pmid">22707990</pub-id></mixed-citation>
</ref>
<ref id="b102-ad-9-3-537">
<label>[102]</label>
<mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>L</given-names></name>, <name><surname>He</surname><given-names>D</given-names></name>, <name><surname>Han</surname><given-names>L</given-names></name>, <name><surname>Cao</surname><given-names>H</given-names></name> (<year>2015</year>). <article-title>Stroke Research in China over the Past Decade: Analysis of NSFC Funding</article-title>. <source/>Transl Stroke Res, <volume>6</volume>: <fpage>253</fpage>-<lpage>256</lpage><pub-id pub-id-type="pmid">26040422</pub-id></mixed-citation>
</ref>
<ref id="b103-ad-9-3-537">
<label>[103]</label>
<mixed-citation publication-type="journal"><name><surname>Munyon</surname><given-names>CN</given-names></name>, <name><surname>Hart</surname><given-names>DJ</given-names></name> (<year>2015</year>). <article-title>Vascular disease of the spine</article-title>. <source/>Neurologist, <volume>19</volume>: <fpage>121</fpage>-<lpage>127</lpage><pub-id pub-id-type="pmid">25970833</pub-id></mixed-citation>
</ref>
<ref id="b104-ad-9-3-537">
<label>[104]</label>
<mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Di Lorenzo</surname><given-names>A</given-names></name>, <name><surname>Kleaveland</surname><given-names>B</given-names></name>, <name><surname>Zou</surname><given-names>Z</given-names></name>, <name><surname>Seiler</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations</article-title>. <source/>J Clin Invest, <volume>120</volume>: <fpage>2795</fpage>-<lpage>2804</lpage><pub-id pub-id-type="pmid">20592472</pub-id></mixed-citation>
</ref>
<ref id="b105-ad-9-3-537">
<label>[105]</label>
<mixed-citation publication-type="journal"><name><surname>Revencu</surname><given-names>N</given-names></name>, <name><surname>Vikkula</surname><given-names>M</given-names></name> (<year>2006</year>). <article-title>Cerebral cavernous malformation: new molecular and clinical insights</article-title>. <source/>J Med Genet, <volume>43</volume>: <fpage>716</fpage>-<lpage>721</lpage><pub-id pub-id-type="pmid">16571644</pub-id></mixed-citation>
</ref>
<ref id="b106-ad-9-3-537">
<label>[106]</label>
<mixed-citation publication-type="journal"><name><surname>Voss</surname><given-names>K</given-names></name>, <name><surname>Stahl</surname><given-names>S</given-names></name>, <name><surname>Schleider</surname><given-names>E</given-names></name>, <name><surname>Ullrich</surname><given-names>S</given-names></name>, <name><surname>Nickel</surname><given-names>J</given-names></name>, <name><surname>Mueller</surname><given-names>TD</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations</article-title>. <source/>Neurogenetics, <volume>8</volume>: <fpage>249</fpage>-<lpage>256</lpage><pub-id pub-id-type="pmid">17657516</pub-id></mixed-citation>
</ref>
<ref id="b107-ad-9-3-537">
<label>[107]</label>
<mixed-citation publication-type="journal"><name><surname>Sveinsson</surname><given-names>OA</given-names></name>, <name><surname>Kjartansson</surname><given-names>O</given-names></name>, <name><surname>Valdimarsson</surname><given-names>EM</given-names></name> (<year>2014</year>). [<article-title>Cerebral ischemia/infarction - epidemiology, causes and symptoms</article-title>]. <source/>Laeknabladid, <volume>100</volume>: <fpage>271</fpage>-<lpage>279</lpage><pub-id pub-id-type="pmid">24846950</pub-id></mixed-citation>
</ref>
<ref id="b108-ad-9-3-537">
<label>[108]</label>
<mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Yin</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Yan</surname><given-names>F</given-names></name>, <name><surname>He</surname><given-names>Q</given-names></name>, <name><surname>Huang</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>Hippo/MST1 signaling mediates microglial activation following acute cerebral ischemia-reperfusion injury</article-title>. <source/>Brain Behav Immun, <volume>55</volume>: <fpage>236</fpage>-<lpage>248</lpage><pub-id pub-id-type="pmid">26721416</pub-id></mixed-citation>
</ref>
<ref id="b109-ad-9-3-537">
<label>[109]</label>
<mixed-citation publication-type="journal"><name><surname>Davalos</surname><given-names>D</given-names></name>, <name><surname>Grutzendler</surname><given-names>J</given-names></name>, <name><surname>Yang</surname><given-names>G</given-names></name>, <name><surname>Kim</surname><given-names>JV</given-names></name>, <name><surname>Zuo</surname><given-names>Y</given-names></name>, <name><surname>Jung</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2005</year>). <article-title>ATP mediates rapid microglial response to local brain injury in vivo</article-title>. <source/>Nat Neurosci, <volume>8</volume>: <fpage>752</fpage>-<lpage>758</lpage><pub-id pub-id-type="pmid">15895084</pub-id></mixed-citation>
</ref>
<ref id="b110-ad-9-3-537">
<label>[110]</label>
<mixed-citation publication-type="journal"><name><surname>Korzhevskii</surname><given-names>DE</given-names></name>, <name><surname>Lentsman</surname><given-names>MV</given-names></name>, <name><surname>Kirik</surname><given-names>OV</given-names></name>, <name><surname>Otellin</surname><given-names>VA</given-names></name> (<year>2012</year>). [<article-title>Morphological types of activated microglia in the hippocampus observed following transient total brain ischemia</article-title>]. <source/>Morfologiia, <volume>142</volume>: <fpage>30</fpage>-<lpage>33</lpage></mixed-citation>
</ref>
<ref id="b111-ad-9-3-537">
<label>[111]</label>
<mixed-citation publication-type="journal"><name><surname>Kaushal</surname><given-names>V</given-names></name>, <name><surname>Schlichter</surname><given-names>LC</given-names></name> (<year>2008</year>). <article-title>Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra</article-title>. <source/>J Neurosci, <volume>28</volume>: <fpage>2221</fpage>-<lpage>2230</lpage><pub-id pub-id-type="pmid">18305255</pub-id></mixed-citation>
</ref>
<ref id="b112-ad-9-3-537">
<label>[112]</label>
<mixed-citation publication-type="journal"><name><surname>Weng</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Zheng</surname><given-names>W</given-names></name>, <name><surname>Meng</surname><given-names>H</given-names></name>, <name><surname>Han</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>Malibatol A enhances alternative activation of microglia by inhibiting phosphorylation of Mammalian Ste20-like kinase1 in OGD-BV-2 cells</article-title>. <source/>Neurol Res, <volume>38</volume>: <fpage>342</fpage>-<lpage>348</lpage><pub-id pub-id-type="pmid">27098434</pub-id></mixed-citation>
</ref>
<ref id="b113-ad-9-3-537">
<label>[113]</label>
<mixed-citation publication-type="journal"><name><surname>Orihuela</surname><given-names>R</given-names></name>, <name><surname>McPherson</surname><given-names>CA</given-names></name>, <name><surname>Harry</surname><given-names>GJ</given-names></name> (<year>2016</year>). <article-title>Microglial M1/M2 polarization and metabolic states</article-title>. <source/>Br J Pharmacol, <volume>173</volume>: <fpage>649</fpage>-<lpage>665</lpage><pub-id pub-id-type="pmid">25800044</pub-id></mixed-citation>
</ref>
<ref id="b114-ad-9-3-537">
<label>[114]</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>N</given-names></name>, <name><surname>Liu</surname><given-names>BW</given-names></name>, <name><surname>Ren</surname><given-names>WZ</given-names></name>, <name><surname>Liu</surname><given-names>JX</given-names></name>, <name><surname>Li</surname><given-names>SN</given-names></name>, <name><surname>Fu</surname><given-names>SP</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-kappaB Signaling Pathways</article-title>. <source/>Int J Mol Sci, <volume>17</volume>: <fpage>190</fpage><pub-id pub-id-type="pmid">26861286</pub-id></mixed-citation>
</ref>
<ref id="b115-ad-9-3-537">
<label>[115]</label>
<mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Su</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>N</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>Tanshinol suppresses inflammatory factors in a rat model of vascular dementia and protects LPS-treated neurons via the MST1-FOXO3 signaling pathway</article-title>. <source/>Brain Res, <volume>1646</volume>: <fpage>304</fpage>-<lpage>314</lpage><pub-id pub-id-type="pmid">27317635</pub-id></mixed-citation>
</ref>
<ref id="b116-ad-9-3-537">
<label>[116]</label>
<mixed-citation publication-type="journal"><name><surname>Nagata</surname><given-names>K</given-names></name> (<year>2014</year>). [<article-title>Alzheimerâs disease and vascular dementia</article-title>]. <source/>Nihon Rinsho, <volume>72</volume>: <fpage>618</fpage>-<lpage>630</lpage><pub-id pub-id-type="pmid">24796089</pub-id></mixed-citation>
</ref>
<ref id="b117-ad-9-3-537">
<label>[117]</label>
<mixed-citation publication-type="journal"><name><surname>Kumawat</surname><given-names>KL</given-names></name>, <name><surname>Kaushik</surname><given-names>DK</given-names></name>, <name><surname>Goswami</surname><given-names>P</given-names></name>, <name><surname>Basu</surname><given-names>A</given-names></name> (<year>2014</year>). <article-title>Acute exposure to lead acetate activates microglia and induces subsequent bystander neuronal death via caspase-3 activation</article-title>. <source/>Neurotoxicology, <volume>41</volume>: <fpage>143</fpage>-<lpage>153</lpage><pub-id pub-id-type="pmid">24530660</pub-id></mixed-citation>
</ref>
<ref id="b118-ad-9-3-537">
<label>[118]</label>
<mixed-citation publication-type="journal"><name><surname>Bruning</surname><given-names>CA</given-names></name>, <name><surname>Prigol</surname><given-names>M</given-names></name>, <name><surname>Luchese</surname><given-names>C</given-names></name>, <name><surname>Jesse</surname><given-names>CR</given-names></name>, <name><surname>Duarte</surname><given-names>MM</given-names></name>, <name><surname>Roman</surname><given-names>SS</given-names></name>, <etal>et al</etal> (<year>2012</year>). <article-title>Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines</article-title>. <source/>Neurochem Res, <volume>37</volume>: <fpage>2249</fpage>-<lpage>2258</lpage><pub-id pub-id-type="pmid">22846969</pub-id></mixed-citation>
</ref>
<ref id="b119-ad-9-3-537">
<label>[119]</label>
<mixed-citation publication-type="journal"><name><surname>Chodobski</surname><given-names>A</given-names></name>, <name><surname>Zink</surname><given-names>BJ</given-names></name>, <name><surname>Szmydynger-Chodobska</surname><given-names>J</given-names></name> (<year>2011</year>). <article-title>Blood-brain barrier pathophysiology in traumatic brain injury</article-title>. <source/>Transl Stroke Res, <volume>2</volume>: <fpage>492</fpage>-<lpage>516</lpage><pub-id pub-id-type="pmid">22299022</pub-id></mixed-citation>
</ref>
<ref id="b120-ad-9-3-537">
<label>[120]</label>
<mixed-citation publication-type="journal"><name><surname>Zuliani</surname><given-names>G</given-names></name>, <name><surname>Guerra</surname><given-names>G</given-names></name>, <name><surname>Ranzini</surname><given-names>M</given-names></name>, <name><surname>Rossi</surname><given-names>L</given-names></name>, <name><surname>Munari</surname><given-names>MR</given-names></name>, <name><surname>Zurlo</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2007</year>). <article-title>High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia</article-title>. <source/>Int J Geriatr Psychiatry, <volume>22</volume>: <fpage>305</fpage>-<lpage>311</lpage><pub-id pub-id-type="pmid">17022108</pub-id></mixed-citation>
</ref>
<ref id="b121-ad-9-3-537">
<label>[121]</label>
<mixed-citation publication-type="journal"><name><surname>Gallacher</surname><given-names>J</given-names></name>, <name><surname>Bayer</surname><given-names>A</given-names></name>, <name><surname>Lowe</surname><given-names>G</given-names></name>, <name><surname>Fish</surname><given-names>M</given-names></name>, <name><surname>Pickering</surname><given-names>J</given-names></name>, <name><surname>Pedro</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2010</year>). <article-title>Is sticky blood bad for the brain?: Hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study</article-title>. <source/>Arterioscler Thromb Vasc Biol, <volume>30</volume>: <fpage>599</fpage>-<lpage>604</lpage><pub-id pub-id-type="pmid">19965782</pub-id></mixed-citation>
</ref>
<ref id="b122-ad-9-3-537">
<label>[122]</label>
<mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>LB</given-names></name>, <name><surname>Yu</surname><given-names>XF</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Zhou</surname><given-names>D</given-names></name> (<year>2016</year>). <article-title>Alzheimerâs Disease therapeutics: current and future therapies</article-title>. <source/>Minerva Med, <volume>107</volume>: <fpage>108</fpage>-<lpage>113</lpage><pub-id pub-id-type="pmid">26933835</pub-id></mixed-citation>
</ref>
<ref id="b123-ad-9-3-537">
<label>[123]</label>
<mixed-citation publication-type="journal"><name><surname>Tulsulkar</surname><given-names>J</given-names></name>, <name><surname>Glueck</surname><given-names>B</given-names></name>, <name><surname>Hinds</surname><given-names>TD</given-names><suffix>Jr.</suffix></name>, <name><surname>Shah</surname><given-names>ZA</given-names></name> (<year>2016</year>). <article-title>Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt Pathway</article-title>. <source/>Transl Stroke Res, <volume>7</volume>: <fpage>120</fpage>-<lpage>131</lpage><pub-id pub-id-type="pmid">26573919</pub-id></mixed-citation>
</ref>
<ref id="b124-ad-9-3-537">
<label>[124]</label>
<mixed-citation publication-type="journal"><name><surname>Trojanowski</surname><given-names>JQ</given-names></name>, <name><surname>Lee</surname><given-names>VM</given-names></name> (<year>2002</year>). <article-title>The role of tau in Alzheimerâs disease</article-title>. <source/>Med Clin North Am, <volume>86</volume>: <fpage>615</fpage>-<lpage>627</lpage><pub-id pub-id-type="pmid">12168561</pub-id></mixed-citation>
</ref>
<ref id="b125-ad-9-3-537">
<label>[125]</label>
<mixed-citation publication-type="journal"><name><surname>Hardy</surname><given-names>J</given-names></name>, <name><surname>Orr</surname><given-names>H</given-names></name> (<year>2006</year>). <article-title>The genetics of neurodegenerative diseases</article-title>. <source/>J Neurochem, <volume>97</volume>: <fpage>1690</fpage>-<lpage>1699</lpage><pub-id pub-id-type="pmid">16805777</pub-id></mixed-citation>
</ref>
<ref id="b126-ad-9-3-537">
<label>[126]</label>
<mixed-citation publication-type="journal"><name><surname>Peters</surname><given-names>OM</given-names></name>, <name><surname>Ghasemi</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>RH</given-names><suffix>Jr.</suffix></name>, (<year>2015</year>). <article-title>Emerging mechanisms of molecular pathology in ALS</article-title>. <source/>J Clin Invest, <volume>125</volume>: <fpage>1767</fpage>-<lpage>1779</lpage><pub-id pub-id-type="pmid">25932674</pub-id></mixed-citation>
</ref>
<ref id="b127-ad-9-3-537">
<label>[127]</label>
<mixed-citation publication-type="journal"><name><surname>Rodrigues</surname><given-names>MC</given-names></name>, <name><surname>Voltarelli</surname><given-names>JC</given-names></name>, <name><surname>Sanberg</surname><given-names>PR</given-names></name>, <name><surname>Borlongan</surname><given-names>CV</given-names></name>, <name><surname>Garbuzova-Davis</surname><given-names>S</given-names></name> (<year>2012</year>). <article-title>Immunological aspects in amyotrophic lateral sclerosis</article-title>. <source/>Transl Stroke Res, <volume>3</volume>: <fpage>331</fpage>-<lpage>340</lpage><pub-id pub-id-type="pmid">24323808</pub-id></mixed-citation>
</ref>
<ref id="b128-ad-9-3-537">
<label>[128]</label>
<mixed-citation publication-type="journal"><name><surname>Cleveland</surname><given-names>DW</given-names></name>, <name><surname>Rothstein</surname><given-names>JD</given-names></name> (<year>2001</year>). <article-title>From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS</article-title>. <source/>Nat Rev Neurosci, <volume>2</volume>: <fpage>806</fpage>-<lpage>819</lpage><pub-id pub-id-type="pmid">11715057</pub-id></mixed-citation>
</ref>
<ref id="b129-ad-9-3-537">
<label>[129]</label>
<mixed-citation publication-type="journal"><name><surname>Pasinelli</surname><given-names>P</given-names></name>, <name><surname>Brown</surname><given-names>RH</given-names></name> (<year>2006</year>). <article-title>Molecular biology of amyotrophic lateral sclerosis: insights from genetics</article-title>. <source/>Nat Rev Neurosci, <volume>7</volume>: <fpage>710</fpage>-<lpage>723</lpage><pub-id pub-id-type="pmid">16924260</pub-id></mixed-citation>
</ref>
<ref id="b130-ad-9-3-537">
<label>[130]</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>JK</given-names></name>, <name><surname>Shin</surname><given-names>JH</given-names></name>, <name><surname>Hwang</surname><given-names>SG</given-names></name>, <name><surname>Gwag</surname><given-names>BJ</given-names></name>, <name><surname>McKee</surname><given-names>AC</given-names></name>, <name><surname>Lee</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2013</year>). <article-title>MST1 functions as a key modulator of neurodegeneration in a mouse model of ALS</article-title>. <source/>Proc Natl Acad Sci U S A, <volume>110</volume>: <fpage>12066</fpage>-<lpage>12071</lpage><pub-id pub-id-type="pmid">23818595</pub-id></mixed-citation>
</ref>
<ref id="b131-ad-9-3-537">
<label>[131]</label>
<mixed-citation publication-type="journal"><name><surname>Chae</surname><given-names>JS</given-names></name>, <name><surname>Gil Hwang</surname><given-names>S</given-names></name>, <name><surname>Lim</surname><given-names>DS</given-names></name>, <name><surname>Choi</surname><given-names>EJ</given-names></name> (<year>2012</year>). <article-title>Thioredoxin-1 functions as a molecular switch regulating the oxidative stress-induced activation of MST1</article-title>. <source/>Free Radic Biol Med, <volume>53</volume>: <fpage>2335</fpage>-<lpage>2343</lpage><pub-id pub-id-type="pmid">23085515</pub-id></mixed-citation>
</ref>
<ref id="b132-ad-9-3-537">
<label>[132]</label>
<mixed-citation publication-type="journal"><name><surname>Dewil</surname><given-names>M</given-names></name>, <name><surname>dela Cruz</surname><given-names>VF</given-names></name>, <name><surname>Van Den Bosch</surname><given-names>L</given-names></name>, <name><surname>Robberecht</surname><given-names>W</given-names></name> (<year>2007</year>). <article-title>Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death</article-title>. <source/>Neurobiol Dis, <volume>26</volume>: <fpage>332</fpage>-<lpage>341</lpage><pub-id pub-id-type="pmid">17346981</pub-id></mixed-citation>
</ref>
<ref id="b133-ad-9-3-537">
<label>[133]</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Ona</surname><given-names>VO</given-names></name>, <name><surname>Guegan</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>M</given-names></name>, <name><surname>Jackson-Lewis</surname><given-names>V</given-names></name>, <name><surname>Andrews</surname><given-names>LJ</given-names></name>, <etal>et al</etal> (<year>2000</year>). <article-title>Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model</article-title>. <source/>Science, <volume>288</volume>: <fpage>335</fpage>-<lpage>339</lpage><pub-id pub-id-type="pmid">10764647</pub-id></mixed-citation>
</ref>
<ref id="b134-ad-9-3-537">
<label>[134]</label>
<mixed-citation publication-type="journal"><name><surname>Hara</surname><given-names>T</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <name><surname>Matsui</surname><given-names>M</given-names></name>, <name><surname>Yamamoto</surname><given-names>A</given-names></name>, <name><surname>Nakahara</surname><given-names>Y</given-names></name>, <name><surname>Suzuki-Migishima</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2006</year>). <article-title>Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice</article-title>. <source/>Nature, <volume>441</volume>: <fpage>885</fpage>-<lpage>889</lpage><pub-id pub-id-type="pmid">16625204</pub-id></mixed-citation>
</ref>
<ref id="b135-ad-9-3-537">
<label>[135]</label>
<mixed-citation publication-type="journal"><name><surname>Prusiner</surname><given-names>SB</given-names></name> (<year>1991</year>). <article-title>Molecular biology of prion diseases</article-title>. <source/>Science, <volume>252</volume>: <fpage>1515</fpage>-<lpage>1522</lpage><pub-id pub-id-type="pmid">1675487</pub-id></mixed-citation>
</ref>
<ref id="b136-ad-9-3-537">
<label>[136]</label>
<mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>DR</given-names></name>, <name><surname>Schmidt</surname><given-names>B</given-names></name>, <name><surname>Kretzschmar</surname><given-names>HA</given-names></name> (<year>1996</year>). <article-title>Role of microglia and host prion protein in neurotoxicity of a prion protein fragment</article-title>. <source/>Nature, <volume>380</volume>: <fpage>345</fpage>-<lpage>347</lpage><pub-id pub-id-type="pmid">8598929</pub-id></mixed-citation>
</ref>
<ref id="b137-ad-9-3-537">
<label>[137]</label>
<mixed-citation publication-type="journal"><name><surname>Turnbull</surname><given-names>S</given-names></name>, <name><surname>Tabner</surname><given-names>BJ</given-names></name>, <name><surname>Brown</surname><given-names>DR</given-names></name>, <name><surname>Allsop</surname><given-names>D</given-names></name> (<year>2003</year>). <article-title>Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126</article-title>. <source/>Neuroreport, <volume>14</volume>: <fpage>1743</fpage>-<lpage>1745</lpage><pub-id pub-id-type="pmid">14512849</pub-id></mixed-citation>
</ref>
<ref id="b138-ad-9-3-537">
<label>[138]</label>
<mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>B</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Zhou</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2014</year>). <article-title>C-Abl tyrosine kinase mediates neurotoxic prion peptide-induced neuronal apoptosis via regulating mitochondrial homeostasis</article-title>. <source/>Mol Neurobiol, <volume>49</volume>: <fpage>1102</fpage>-<lpage>1116</lpage><pub-id pub-id-type="pmid">24510275</pub-id></mixed-citation>
</ref>
<ref id="b139-ad-9-3-537">
<label>[139]</label>
<mixed-citation publication-type="journal"><name><surname>Burns</surname><given-names>AS</given-names></name>, <name><surname>OâConnell</surname><given-names>C</given-names></name> (<year>2012</year>). <article-title>The challenge of spinal cord injury care in the developing world</article-title>. <source/>J Spinal Cord Med, <volume>35</volume>: <fpage>3</fpage>-<lpage>8</lpage><pub-id pub-id-type="pmid">22330185</pub-id></mixed-citation>
</ref>
<ref id="b140-ad-9-3-537">
<label>[140]</label>
<mixed-citation publication-type="journal"><name><surname>An</surname><given-names>C</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <name><surname>Pu</surname><given-names>H</given-names></name>, <name><surname>Hong</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Hu</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2016</year>). <article-title>Severity-Dependent Long-Term Spatial Learning-Memory Impairment in a Mouse Model of Traumatic Brain Injury</article-title>. <source/>Transl Stroke Res, <volume>7</volume>: <fpage>512</fpage>-<lpage>520</lpage><pub-id pub-id-type="pmid">27539574</pub-id></mixed-citation>
</ref>
<ref id="b141-ad-9-3-537">
<label>[141]</label>
<mixed-citation publication-type="journal"><name><surname>Terson de Paleville</surname><given-names>DG</given-names></name>, <name><surname>McKay</surname><given-names>WB</given-names></name>, <name><surname>Folz</surname><given-names>RJ</given-names></name>, <name><surname>Ovechkin</surname><given-names>AV</given-names></name> (<year>2011</year>). <article-title>Respiratory motor control disrupted by spinal cord injury: mechanisms, evaluation, and restoration</article-title>. <source/>Transl Stroke Res, <volume>2</volume>: <fpage>463</fpage>-<lpage>473</lpage><pub-id pub-id-type="pmid">22408690</pub-id></mixed-citation>
</ref>
<ref id="b142-ad-9-3-537">
<label>[142]</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>, <name><surname>Tian</surname><given-names>T</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Zhao</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2015</year>). <article-title>Mst3b promotes spinal cord neuronal regeneration by promoting growth cone branching out in spinal cord injury rats</article-title>. <source/>Mol Neurobiol, <volume>51</volume>: <fpage>1144</fpage>-<lpage>1157</lpage><pub-id pub-id-type="pmid">24990316</pub-id></mixed-citation>
</ref>
<ref id="b143-ad-9-3-537">
<label>[143]</label>
<mixed-citation publication-format="print" publication-type="book"><name><surname>Doherty</surname><given-names>ES</given-names></name>, <name><surname>Lacbawan</surname><given-names>FL</given-names></name> (<year>1993</year>) <article-title>2q37 Microdeletion Syndrome</article-title>. In <source/>GeneReviews(R) (<name><surname>Pagon</surname><given-names>R. A.</given-names></name>, <name><surname>Adam</surname><given-names>M. P.</given-names></name>, <name><surname>Ardinger</surname><given-names>H. H.</given-names></name>, <name><surname>Wallace</surname><given-names>S. E.</given-names></name>, <name><surname>Amemiya</surname><given-names>A.</given-names></name>, <name><surname>Bean</surname><given-names>L. J. H.</given-names></name>, <etal>et al</etal>, eds), <publisher-loc>Seattle (WA)</publisher-loc></mixed-citation>
</ref>
<ref id="b144-ad-9-3-537">
<label>[144]</label>
<mixed-citation publication-type="journal"><name><surname>Aldred</surname><given-names>MA</given-names></name>, <name><surname>Sanford</surname><given-names>RO</given-names></name>, <name><surname>Thomas</surname><given-names>NS</given-names></name>, <name><surname>Barrow</surname><given-names>MA</given-names></name>, <name><surname>Wilson</surname><given-names>LC</given-names></name>, <name><surname>Brueton</surname><given-names>LA</given-names></name>, <etal>et al</etal> (<year>2004</year>). <article-title>Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum deletion intervals for key phenotypes</article-title>. <source/>J Med Genet, <volume>41</volume>: <fpage>433</fpage>-<lpage>439</lpage><pub-id pub-id-type="pmid">15173228</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>